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ADC: Apparent diffusion coefficient 
ATP: Adenosine Triphospate 
ADP: Adenosine Diphosphate 
AIDS: Acquired Immune Deficiency Syndrome 
ANLS: Astrocyte-neuron lactate shuttle 
AVDO2: Arterial-venous difference in oxygen saturation 
BBB: Blood Brain Barrier 
CBF: Cerebral Blood Flow 
CBV: Cerebral Blood Volume 
CCT : Central conduction time 
CMRGLUC: Cerebral metabolic rate of glucose consumption 
CMRO2: Cerebral metabolic rate of oxygen consumption 
CO2: Carbon dioxide 
CPP: Cerebral Perfusion Pressure 
CSF: Cerebrospinal Fluid 
CvO2: Cerebral venous Oxygen content 
DWI: Diffusion weighted imaging 
EAA: Excitatory amino acids 




HBO: Hyperbaric Oxygen 
HIV: Human Immunodeficiency Virus 
1H MRS:  Proton Magnetic Resonance Spectroscopy 
IBV: Ischemic Brain Volume  
ICA: Internal carotid artery 
ICH: Intracranial Hematoma 
ICP: Intracranial Pressure 
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ISF: Interstitial Fluid 
K+: Potassium 
LPR: Lactate Pyruvate Ratio 
MAP: Mean Arterial Pressure 
MCA: Middle Cerebral Artery 
Mhz: Megahertz 
MTT: Mean transit time 
NIRS: Near Infrared Spectroscopy 
PaCO2: Partial pressure of arterial carbon dioxide  
PbtO2: Brain tissue oxygen tension 
PWI : Perfusion weighted imaging 
PET: Positron Emission Tomography  
PI: Pulsatility index 
PaO2: Partial pressure of oxygen 
PRR: Pulse Repetition Rate 
PTCI: Post Traumatic Cerebral Ischemia 
rCBF: Regional cerebral blood flow 
RBC: Red Blood Cells 
ROI: Region of interest 
SAH: Subarachnoid Hemorrhage 
SaO2: Oxygen Saturation 
SDH: Subdural Hematoma 
SjVO2: Jugular Venous Oxygen Saturation (Jugular Venous Oximetry) 
SNR: Signal to noise ratio 
SSEP: Somatosensory evoked potentials 
Tb: Transmitted sound burst 
TBI: Traumatic Brain Injury 
TBV: Total Brain Volume 
TCA: Tricarboxylic acid cycle 
TCD: Transcranial Doppler 




Vs: Peak systolic velocity 
Vd: Peak diastolic velocity 
Vm: Time-averaged mean velocity 





























Autoregulation: A physiological mechanism by which the brain regulates and 
maintains adequate cerebral blood flow to the parenchyma. 
Diaschisis: A reduction in neurometabolic activity remote from the infarct site, due 
to the disconnective effects of the infarct, with loss of afferent signals to other regions 
of the brain. 
Hypoxia: A reduction in tissue PO2 to levels insufficient to maintain cellular 
function, metabolism and structure. 
Incidence: The number of new cases of a disease in a defined population over a 
specific period of time. 
Infarction: Sudden insufficiency of arterial or venous blood supply due to emboli, 
thrombi, vascular torsion, or pressure that produces a macroscopic area of necrosis. 
Ischemia: Inadequate circulation of blood to sustain normal tissue function, 
structure or metabolism.  
Metabolic crisis: The elevation of the lactate/pyruvate ratio (LPR) > 40, seen after 
severe TBI (142) – this is a microdialysis based definition, as reflected by abnormal 
cerebral microdialysis LPR, in the context of TBI. This definition is differentiated, 
contextually, from other definitions of metabolic crisis, which usually relate to 
inborn errors of metabolism often associated with mortality in neonates.   
Penumbra: Area immediately surrounding a region of vascular compromise. 
Perfusion: Tissue blood flow or blood flow in the microvasculature. This is the rate 
which the quantity of blood in a given mass or volume of tissue is replenished at the 
level of the capillaries. Perfusion is often given in the units ml/100g/min.   
Pressure-passive flow: A pathological situation where CBF is passively determined 
by MAP due to failure of autoregulation.  
Prevalence: The number of cases of a disease existing in a given population at a 
specific period of time or at a particular moment in time. 




Secondary injury: Injury sustained after the initial insult, may be prevented and is 
often reversible. 
Thermal conduction: The ability of a solid medium, such as tissue , to transport heat 
(thermal energy). 
Thermal convection: The ability of a fluid medium, such as blood, to transport heat 
(thermal energy).   
Thermistor: An electrical element that changes its resistance in response to a 
temperature change. 
Voxels: A contraction for volume element, which is the basic unit of CT 
























CHAPTER 1: INTRODUCTION 
 
Severe traumatic brain injury (TBI) is a major cause of mortality and disability in 
both adults and children. While most of these injuries in children may be mild, any 
injury to the developing brain is important because it may still cause some degree of 
long-term deficit. Those who sustain severe head injury have a high mortality and 
survivors often demonstrate severe functional and cognitive impairment so TBI is a 
major health and socioeconomic concern (1, 2, 3). The incidence of TBI varies 
between 100 and 250 per 100 000 in western industrialized countries (5, 9, 10). 
However, TBI, and in particular, pediatric TBI continues to receive inadequate 
funding for both basic science and clinical research (4), especially when compared 
with funding for infectious diseases like tuberculosis and HIV/AIDS.  
The outcome in head injury is not only related to the severity of the initial injury, but 
also to how well the patient is managed in the acute period following the injury, i.e. 
prevention of secondary injury (6, 7, 292, 293). Secondary injury includes 
hypoxia/ischemia, hypotension, hyperthermia, brain oedema, delayed intracerebral 
hematoma (ICH), dysautoregulation of cerebral vasculature, metabolic 
abnormalities, raised intracranial pressure, infection, seizures and extracranial 
causes eg. chest infection. Secondary injuries are important because they represent 
an opportunity for the treating physician to intervene and therefore to have an 
influence on outcome. In particular cerebral ischemia may be a major factor leading 
to poor outcome. It is well recognized that global cerebral blood flow (CBF) is lower 
in head injured patients when compared to age-matched controls (120, 122), and 
some have suggested that cerebral ischemia may be the single most important cause 
of secondary brain injury after severe head trauma (121, 122, 123, 124), supported by 
histological evidence that ischemic brain damage is common in most head injured 
patients who die (13, 14). 
Alterations in CBF play a major role in the pathophysiology of severe head injury (7, 
8, 12). Several factors influence CBF dynamically in head-injured patients. In TBI, 
one of the major determinants of CBF and hence perfusion of the injured brain is 
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cerebral perfusion pressure (CPP), which is the difference between mean arterial 
pressure (MAP) and intracranial pressure (ICP). CBF is usually controlled within a 
wide range of blood pressure changes by the capacity of the cerebrovascular bed to 
vary the diameter of the arterioles (pressure autoregulation). Disruption of the 
autoregulatory capacity in the head injured patient impairs the capacity of the brain 
to respond to changes in perfusion pressure and places the brain at higher risk of 
ischemia. Several other factors also affect CBF, including the metabolic activity of the 
brain, systemic changes in carbon dioxide (CO2) and oxygenation, temperature and 
pH. Each of these factors may be influenced by therapies implemented in the ICU 
and may be relevant to the overall burden of ischemia. 
Although it has generally been accepted that cerebral ischemia is an important factor 
influencing outcome from head injury, attempts to demonstrate where, why and 
how often true ischemia occurs in the brain, have stirred debate (11). In TBI, the 
issue is more complex than it is in stroke models. Accurate demonstration of 
ischemia in TBI has proved elusive, because regional reductions in CBF may actually 
represent areas of hypoperfusion, which are appropriately coupled to areas of 
hypometabolism (metabolic coupling). Most commonly quoted thresholds for CBF 
and cerebral oxygen metabolism (CMRO2) are based on experimental studies of 
ischemia and clinical stroke, but these cannot necessarily be directly translated to TBI 
(23, 29, 32, 33, 39, 40). 
There are currently various methods for measuring CBF, cerebral blood volume 
(CBV) and cerebral oxygenation, or surrogates of these, all of which have different 
strengths and limitations. These include techniques such as positron emission 
tomography (PET), xenon enhanced CT scan (Xe-CT), single photon emission CT 
(SPECT), perfusion CT, MRI sequences, transcranial doppler flow measurements 
(TCD), jugular bulb oxygen saturation (SjvO2), near infrared spectroscopy (NIRS), 
brain tissue oxygenation (PbtO2), thermal diffusion regional CBF measurements, 
microdialysis (MD), electroencephalography (EEG) and somatosensory evoked 
potentials (SSEP). None of these methods are independently able to effectively 
diagnose ischemia continuously in the neurocritical care unit. Therefore it is up to 
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the clinician to evaluate the strengths and weaknesses of each and use them 
appropriately in the clinical environment. 
Several studies have reported ischemia after TBI (11, 13, 14, 15, 16, 17, 22, 139, 141, 
142, 149, 159). The most compelling evidence supporting the occurrence of ischemia 
after TBI comes from early studies based on findings from autopsies of fatal TBI 
cases, which suggest a relatively high frequency (13, 14). Most of the ischemic 
damage demonstrated was found in well localized anatomical areas, including the 
hippocampus, basal ganglia and cerebellum. More recent evidence supporting a 
high frequency of ischemia post-TBI in antemortem studies were based on 
hyperacute studies of CBF, and SjvO2 (11, 15, 16, 17). These findings have been 
confirmed by others over the past two decades (18, 19). However recent PET studies 
of cerebral ischemia after TBI have re-invigorated the discussion, with one study in 
particular suggesting that the frequency of true ischemia after TBI may actually be 
quite low (142). These PET studies are important to consider because PET is 
currently considered the gold standard for diagnosing complex vascular and 
metabolic alterations in the brain, including ischemia. However, PET studies have 
significant temporal limitations, and provide a snapshot of the brain at one 
particular time, whereas TBI is a complex, dynamic condition. Also, PET studies, can 
only be performed on patients who are relatively stable. On the other hand, 
continuous methods for measuring brain perfusion or oxygenation also have several 
weaknesses, in particular the focal nature of their monitoring capability. And so, in 
terms of monitoring or diagnostic strategies, the options we have available in TBI 
tend to fall into one of two categories: either 1) the method has good spatial 
resolution and is more specific, but can only provide a ‗snapshot‘ of the brain at one 
point in time (poor temporal resolution), or 2) the method is continuous but is less 
specific and has limited spatial resolution. However, studies using methods from 
each of these two categories tend to generalize their findings. This is not always 
appropriate, especially given the inter- and intra-individual heterogeneity of TBI. In 
individual patients, TBI is a dynamic condition in which different parts of the brain 
may react differently depending on several underlying factors, and which changes 
over time, often dramatically. 
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Therefore the present study was undertaken to examine the comparison of a single 
method used both as a ‗snapshot‘ modality and as a continuous one. A single 
method was chosen so that the comparisons would be appropriate. Even though the 
data from this study cannot be compared to other studies or extrapolated to other 
methods, it is a useful comparison of the type of information that one would obtain 
when a point-in-time method is used in comparison with continuous monitoring, 
and so may serve to provide greater insight into the dynamic nature of TBI. 
For this purpose, PbtO2 monitoring in children was chosen. The aim was to examine 
the frequency of low PbtO2 at selected time points (which reflects the prevalence at 
those time points in this series) and compare these with the frequency of the same 
episodes calculated over the complete duration of monitoring (which better reflects 
the incidence of the condition). 
The work is structured in 2 parts, the first part comprises chapters 1 to 4, which 
reviews the background to the topic, while chapters 5 onwards specifically address 
the present study. Specifically, chapter 2 reviews the important physiological 
concepts relevant to this thesis, chapter 3 describes the pathophysiology of cerebral 
ischemia in TBI, chapter 4 will discuss the methods of monitoring and measuring 
CBF, PbtO2 and cerebral ischemia, and chapter 5 is a review of literature available on 
the subject. Chapter 6 will describe the study design and research methods used for 










CHAPTER 2:  Relevant physiological aspects of cerebral 
blood flow and oxygen metabolism. 
 
Some of the basic physiological mechanisms and principles involved in 
the regulation of cerebral blood flow (CBF), oxygen delivery (DO2) and 
oxygen metabolism are discussed in this section. 
 
Cerebral blood flow (CBF) 
Average CBF (average between grey and white matter) is approximately 50-
55ml/100g/min, representing about 20% of the cardiac output at rest, even though 
the adult brain represents 2-3% of the total body weight. The brain also uses 20% of 
the oxygen and 25% of the glucose consumed by the entire body. More than 90% of 
the oxygen consumed by the brain is used by mitochondria to generate ATP (124). 
However, CBF throughout the brain is heterogeneous, depending on the level of 
metabolic activity in the area and the type of tissue being measured. The flow rate to 
grey matter is about 70ml/100g/min, compared to 20ml/100g/min in white matter, 
due to the higher concentration of neuropils and synapses in grey matter. In general 
the rate of global CBF is kept relatively constant through cerebral pressure 
autoregulation. 
Cerebral pressure autoregulation is a complex mechanism by which the brain 
controls and maintains adequate CBF through active constriction and dilation of 
cerebral arterioles to achieve a relatively constant substrate delivery to the brain.  To 
maintain normal brain tissue substrate delivery, the brain has to regulate both 
regional and total blood flows at a fairly constant rate over a wide range of mean 
arterial blood pressures (MAP) viz. 50mmHg – 160mmHg (127). The adjustment in 
CBF is facilitated by vasoconstriction or dilatation of resistance vessels, which are 
approximately 200 micrometers in diameter.  When MAP increases or decreases 
beyond these thresholds, CBF has a linear relationship with blood pressure; 
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therefore CBF may vary in a number of pathological conditions when 1) the normal 
limits of autoregulation are breeched, or 2) when autoregulation is impaired. Local 
CBF is also determined by various physical properties, as described in Virchow‘s 
triad of hemodynamic parameters for venous thrombosis, namely, the rate of blood 
flow, the status of the vessel wall and the blood coagulability (51). Some of these are 
represented in the Hagen-Poiseuille equation for general hemodynamics : 
                            Q =  
Here, Q refers to blood flow, R refers to vessel radius, ŋ refers to blood viscosity, ΔP 
refers to change in pressure and L to vessel length, therefore blood flow varies 
proportionately with changes in vessel radius and inversely with blood viscosity 
(52). 
It is important to appreciate that children and adults differ with respect to cerebral 
hemodynamics in the physiological and pathological state. The brain of a child is 
still developing and therefore reacts very differently to similar insults sustained in 
an adult. These variations occur for a number of reasons, which include anatomical 
differences (such as the size of the head relative to the body and open skull sutures) 
and physiological differences. The latter are due largely to processes of maturation 
and development, and include, variation in the amount of white and grey matter 
and variable water content, cerebral vasculature variations and incomplete white 
matter myelination, amongst many other features (53, 55, 56). While older studies 
did not take into consideration the developmental and gender-related differences in 
the physiological and cerebrovascular parameters of healthy children, recent data, 
mostly from TCD studies, suggest that CBF varies by age and gender (199, 200, 201, 
202, 204, 205). TCD measures CBF velocity and not CBF directly, but changes in CBF 
velocity have been shown to correlate well with changes in CBF (203, 204). Gender-
related differences in autoregulation and CBF velocity in the anterior and posterior 
circulation have been demonstrated (201). Vavilala et al, showed that girls between 
the ages of 10–16 years old demonstrated higher flow velocities in both the MCA and 
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basilar arteries than boys, while boys demonstrated greater autoregulation of the 
MCA and poorer autoregulation of the basilar artery than girls (201). These 
differences may be influenced by variations in blood viscosity, vessel size, cerebral 
metabolism or cerebrovascular resistance (202). TCD studies also suggest that CBF 
velocity increases with age until 6-9 years, with a decrease in CBF velocity after the 
age of 10 years (199, 200). Data from a PET study demonstrated that regional CBF 
(rCBF) in the < 1 year old age group is lower than in older children, with an increase 
in rCBF in infants, followed by a gradual decrease in adolescence to adult levels 
(273). A few reports have proposed that the ‗excess‘ nerve cells and synapses 
produced during fetal development will start to denature and undergo a process of 
neural pruning, as part of  normal development, occurring during the neonatal 
period and well in to adolescence (274 – 277). The remaining axons will undergo 
myelination, followed by rapid generation of synapses (275, 278, 279). Myelination 
begins in the fetal period, with a rapid increase in synaptogenesis in the neonatal 
period, peaking in childhood and continuing into adolescence. The aforementioned 
physiological correlations may explain some of the developmental changes seen in 
rCBF, as the increase in rCBF and regional cerebral metabolic rate of oxygen 
consumption (rCMRO2) observed in the neonatal and early childhood periods would 
be necessary to sustain myelination and synapse development. There have also been 
reports of developmental, regional heterogeneity, where CBF was higher in the 
thalamus than in other brain regions at birth (280), more prominent in the occipital 
lobe between the ages of 1 and 4 years and highest in the frontal lobe over the age of 
5 years (281). Ideally, many of these factors, if not all, should be taken into account 
when interpreting CBF and metabolic changes in pediatric TBI, given that cerebral 
hypoperfusion (CBF < 25ml/100g/min) appears to be a major physiological 
derangement that has been associated with poor outcome (11, 205, 206).   
Local CBF and arterial oxygen content are the main determinants of oxygen delivery 
to brain tissue. It has been well documented that time-dependent neuronal events 
occur in response to a reduction in CBF (125, 126, 157, 159, 160). The brain has critical 
thresholds for CBF, which are fundamental to defining the thresholds for cerebral 
ischemia. A reduction in CBF to below 20ml/100g/min may lead to loss of 
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consciousness and slowing on the electroencephalogram (EEG), but may not always 
cause any lasting functional impairment. CBF below 5ml/100g/min lasting for more 
than 30 minutes, however, will cause brain infarction (160, 161) [These thresholds 
will be discussed in more detail in the next chapter].  Several factors affect CBF and 
exert these effects to varying degrees. These include cerebral pressure 
autoregulation, as described earlier, CO2 reactivity, O2 reactivity and various 
metabolic parameters, including pH and temperature.   
 
Oxygen delivery (DO2) 
Atmospheric air comprises 21% oxygen, 79% nitrogen and trace amounts of CO2. 
Oxygen is transported from alveolar air to blood, where it is carried by reversible 
binding to hemoglobin (Hb) and then transferred from blood to peripheral tissue by 
diffusion. Oxygen delivery (DO2), denotes the total amount of oxygen delivered to 
the tissues per minute, and can be calculated by the equation : 
DO2 = 1.39 x Hb(g/dl) x SaO2 / 100 x Q / 100, 
where, 1.39 is the oxygen carrying capacity of hemoglobin (in ml/g /Hb), SaO2 is the 
arterial oxygen saturation and Q is cardiac output (262).  The oxygen – hemoglobin 
dissociation curve expresses the affinity of oxygen for hemoglobin. This curve may 
be shifted to the right or left and may be affected by several factors, which include 
those causing a shift to the left: decreased pH, hypocarbia, hypothermia, fetal Hb, 
carboxyhemoglobin, methemoglobin, decreased 2,3 DPG and those causing a shift to 
the right: increased pH, hypercarbia, hyperthermia and increased 2,3 DPG (262). The 
rate of oxygen delivery to peripheral tissue is dependent on the difference in oxygen 
partial pressure (PO2) between capillary and the tissue cells. The physiology of 
oxygen distribution between the cerebral vasculature and brain, however, is still not 
completely understood (122). Constant oxygen delivery is required due to the high 
consumption of oxygen required to sustain mitochondrial activity. This process 
creates an oxygen tension gradient between the capillaries and the tissues, thus 
rendering the magnitude of oxygen flux vital to neuronal integrity. This is 
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important, because if blood flow stays constant, increasing oxygen transport to 
tissues may be achieved by increasing non-hemoglobin bound oxygen i.e. dissolved 
O2. The importance of the dissolved oxygen tension is highlighted by the fact that 
many capillaries are smaller than red blood cell corpuscles, and therefore need to 
dilate in response to local tissue hypoxia, a process possibly mediated by the release 
of nitric oxide. There is also evidence from studies done on rat brain specimens, that 
suggests the existence of ‗acellular blood flow‘ in the brain i.e. capillaries in the brain 
that do not contain erythrocytes (126). 
 
Brain Oxygen Tension 
Due to the consumption of oxygen in the tissue, brain tissue oxygen tension (PbtO2) 
is best described as a continuum that can vary from close to 90mmHg, at points very 
close to capillaries, to much less than 34mmHg in more distal regions (128). It also 
depends on whether grey or white matter is being sampled. PbtO2 can decrease to 
much lower levels in TBI where compromised CBF, decreased oxygen delivery and 
diffusion limitation in the tissues may occur. (128, 129). PbtO2 was found to be 
closely related to the product of CBF and arteriovenous oxygen tension difference, 
suggesting that PbtO2 is related to the diffusion of dissolved plasma oxygen rather 
than the total amount of oxygen released by hemoglobin (158). The demonstrated 
strong relationship between PaO2 and PbtO2 (67), is also the likely cause of 
increasing FiO2 leading to increases in PbtO2. 
 
Brain Oxygen diffusion 
Attempts have been made to describe quantitatively the diffusion of oxygen from 
blood to tissue as well as to define oxygen pressures in brain tissue (130, 131, 132). 
According to Fick‘s first law of diffusion, the driving force for O2 diffusion is the 
difference in PO2 between the two sites viz. from the vessels to the tissues, then 
eventually to the mitochondria. The development of a model describing tissue 
substrate delivery, which was based on the idea that tissues contain a parallel 
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arrangement of capillaries, each supplying a cylindrical volume of tissue, was 
initially suggested by Krogh in the early 1900‘s (133).  He proposed that oxygen 
diffusion occurs radially from capillary blood to tissue and that oxygen consumption 
is constant over time throughout the tissue cylinder. Based on this theory, it follows 
that oxygen content in the proximal capillaries should be high and decreases linearly 
with the distance travelled along the vessel. While this model for diffusion has been 
widely applied and used by researchers, it has distinct shortcomings, which include 
the fact that oxygen diffusion is not limited to capillaries, but also occurs in 
precapillary vessels, and the fact that blood flow in these capillaries is not always 
unidirectional as was originally assumed (134). Even though our knowledge has 
improved significantly since those early years, no single existing theory has 
completely described oxygen transport from the vasculature to the cerebral tissue 
(135). 
 
Cerebral metabolic rate of oxygen (CMRO2) and glucose (CMRGLUC) consumption. 
The CMRO2 of a conscious, normal human being is around 3,5ml/100g/min 
[approximately 20% of resting body O2 consumption] (137). Under normal 
physiological conditions, the human brain consumes oxygen at a rate of 156 
micromol/100g/min and glucose at a rate of 26-31 micromol/100g/min, assuming a 
respiratory quotient of 1 (1mole O2 producing 1mol CO2) (137). When the oxygen is 
delivered to the cell it is used in a variety of cellular reactions. Most oxygen is used 
in the generation of energy via the aerobic metabolism of glucose. It has traditionally 
been assumed that neurons and glia use glucose as their sole source of energy, but 
recent studies have demonstrated that some astrocytes and neurons show the ability 
to use a ‗coupled lactate metabolism‘, where glucose is transported across the BBB, 
and is anaerobically metabolized to lactate (137, 21). Glutamate uptake in astrocytes 
induces a glycolytic response that provides at least some of the necessary cytosolic 
ATP to maintain both glutamate transport and allow its recycling by conversion to 
glutamine. This well known participation of astrocytes in the glutamate/glutamine 
cycle is essential to replenish the neuronal glutamate pool and maintain 
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neurotransmission (252). It has also been suggested by Cerdan et al (253), that lactate 
transfer between astrocytes and neurons occurring as part of the classic astrocyte-
neuron lactate shuttle (ANLS) concept, serves not only the purpose of fueling the 
neuronal tricarboxylic acid (TCA) cycle but also provides reducing equivalents to the 
neuron. Thus the intracellular compartments of astrocytes and neurons are coupled 
and the transfer of lactate is determined by the redox state of each cell, 
predominantly oxidized in neurons due to the largely oxidative metabolism and 
reduced in astrocytes, because of the high glycolytic activity. The ‗redox switch‘ 
described in this theory, also accounts for both the reduction in neuronal glycolysis 
and the favoured lactate utilization by stimulated neurons (253). It has also been 
demonstrated that astrocytes respond to extracellular glucose changes by altering 
their intracellular ATP concentrations, but hypothalamic neurons responded to 
changes in lactate levels instead (254). Therefore, improving energy metabolism by 
enhancing glucose uptake in astrocytes and lactate uptake in neurons, as suggested 
by the ANLS hypothesis, could represent a valuable neuroprotective strategy. (136, 
137, 252). 
 
Effects of oxygen on CBF 
Although hyperoxia may improve the diffusion of oxygen through the tissues, less is 
known about the effects of oxygen on the brain compared with the known 
cerebrovascular responses to changes in blood pressure and CO2, especially in the 
context of TBI. A reduction in perfusion due to vasoconstriction is a known response 
to prolonged hyperoxia, independent of the accompanying arterial hypocapnic 
effects (151). These responses may be mediated by nitric oxide. The cerebral vascular 
and tissue responses to hyperoxia may demonstrate regional differences associated 
with certain pathology (84). Unlike CO2 reactivity, the response of CBF, after 
established hypoxemia, is a longer process, taking about 6 minutes (208, 209). 
Results from animal studies, on the effects of hypoxia, show that CBF does not 
change until systemic PaO2 is less than 50 mmHg. Below this value, there is a 
vasodilatory response and a subsequent increase in CBF (152, 153). Studies in 
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humans, also demonstrate an increase in CBF with moderate hypoxia (91, 102). A 
PaO2 value of less than 58mmHg (7.9kPa) or SaO2 less than 90% is associated with an 
increase in middle cerebral artery (MCA) blood flow velocity and decreased cerebral 
vascular resistance, as measured with TCD  (91). It is therefore important to note, 
particularly in TBI, that the change in CBF with hypoxia is not related to alteration in 
CPP, but rather to changes in local tissue oxygen content (155). 
 
Carbon dioxide (CO2) vasoreactivity 
The cerebral circulation is exquisitely sensitive to changes in PaCO2, a mechanism 
commonly referred to as CO2 vasoreactivity.  CBF increases linearly by 2-4 % per 
mmHg increase in PaCO2, within the range of 25-75 mmHg (210). Changes in CBF 
occur within seconds of altering PaCO2, with complete equilibration usually 
occurring within 2 minutes. Hypercarbia results in vasodilatation and increased 
CBF, whereas hypocarbia results in vasoconstriction and decreased CBF. CO2 
vasoreactivity is usually preserved after severe head injury. It may however be 
weaker in the early stages after injury, but usually returns to the normal 2-4% change 
per mmHg CO2 by 24 hours after injury (214-217). Regional CO2 reactivity differs 
from global CO2 reactivity, as demonstrated by Marion and colleagues (218). Severe 
impairment of CO2 vasoreactivity usually reflects an increased severity of injury and 
a poorer prognosis (215,216). 
Variation in CO2 leads to changes in vessel caliber followed by a passive change in 
CBF. These vessels respond to changes in the pH of the perivascular spaces 
secondary to alterations in PaCO2. CO2 crosses the blood brain barrier freely, and is 
therefore able to change the pH in the perivascular spaces. However, if the new 
PaCO2 level remains constant over the next 24 hours, the pH in the blood and the 
perivascular space as well as the diameter of the cerebral blood vessels, returns to 
baseline (213).  The constant supply of substrate to the brain is maintained at the 
level set by metabolism (CMRO2). Therefore, with CO2 reactivity, changes in CBF are 
compensated for by changes in AVDO2. CBF vasoreactivity in anesthetized healthy 
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children is higher than in adults, according to data derived from studies using 
propofol and volatile anesthetics (211,212). 
 
 Temperature 
The primary temperature regulation centre in humans is the anterior preoptic region 
in the hypothalamus. This centre is responsible for maintaining body temperature at 
36.8 – 37.2 o C (219). The brain temperature itself, is dependent on several factors, 
including: cerebral metabolism, CBF (local, global), and the external environment 
(radiation, conduction and convection). The temperature of incoming arterial blood is 
considered to be the main determinant of brain temperature, particularly for the 
deep brain structures (220). The effect of extracranial temperature on the more 
superficial brain structures is unclear. The thermoregulatory response of the human 
brain to environmental changes, reflects the severity and localization of the cell 
damage (226). Brain temperature is largely assumed to follow core temperature 
when cooling is used. This remains an important issue, as numerous attempts have 
been made to use hypothermia for the treatment of stroke, TBI and multiple sclerosis 
(221-225).  
 
Acid/base (pH) regulation 
The regulation of pH is fundamental to the viability of cells. In this respect, the cells 
in the central nervous system (CNS), do not differ from those found in other tissues, 
and the mechanisms responsible for long-term control of hydrogen ions are similar. 
The cellular diversity of the CNS, however, is unique, and there are a number of 
different acid transport mechanisms encountered in the subtypes of neurons and 
glial cells within the CNS. The acid-base physiology of the CNS is also distinguished 
by the occurrence of rapid changes in H+ ions that arise from electrical activity. 
These changes take place over time periods ranging from milliseconds to minutes, 
involve neurons and glia, and occur in both the intracellular and extracellular 
compartments. The mechanisms that generate and regulate these pH changes are of 
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considerable neurobiological significance, as they may have a modulatory role in 
membrane potential and excitability (227). These mechanisms include Na+/H+ 
exchange, Na+-dependent bicarbonate (HCO3) transport and a passive Cl-/HCO3 
exchanger.  
pH microelectrode studies have shown that brain interstitial fluid is slightly more 
acidic than blood, with a pH of ± 7.3 (229). These studies also show that the low pH 
of the interstitial fluid is entirely due to elevation in tissue pCO2. The high 
concentration of CO2 in post-mortem brain specimens is likely due to its generation 
through aerobic metabolism, and poor clearance, owing to a lack of blood flow. In 
vivo, CO2 is usually cleared by blood flow, which prevents accumulation of CO2. 
With a physiological rise in perfusion, due to elevated neural activity, increased 


















CHAPTER 3: THE PATHOPHYSIOLOGY OF HYPOXIA 
AND ISCHEMIA 
 
Despite the high metabolic demands of the brain and the requirement for continuous 
supply of oxygen and glucose, there is no capacity within the brain for storage of 
oxygen, and only a limited reserve of high energy phosphate compounds and 
carbohydrate reserves. These reserves are only adequate to supply brain tissue for a 
very short period, less than a minute (162, 163), without adequate perfusion, making 
loss of perfusion a major cause of acute brain injury. The terminology and 
subsequent definition of pathological conditions contributing to abnormalities of 
CBF, cerebral oxygenation and cerebral metabolism, have been the subject of much 
discordance and debate. Terms like ‗oligemic cerebral hypoxia‘, ‗metabolic crisis‘, 
‗post traumatic cerebral ischemia‘ or ‗cerebral hypoxia‘, have all been used in the 
description of the pathophysiology following injury to the brain (142).   
Cerebral hypoxia may be described as a reduction in cerebral tissue PO2 levels to a 
level insufficient to maintain cellular function and structure. Hypoxia, is usually 
associated with inadequate ventilation. A decrease in the systemic PaO2 to below 
35mmHg triggers the onset of anaerobic metabolism, which is associated with an 
increase in cerebral glucose consumption, so called hyperglycolysis, and an increase 
in lactate production (164). Apart from the direct effects of systemic hypoxia, 
prolonged systemic hypoxia also often leads to a gradual decrease in blood pressure 
and subsequently reduced cerebral perfusion pressure, a decrease in extracellular 
pH and ultimately, an increase in the lactate/pyruvate ratio. 
Cerebral ischemia implies a reduction of CBF to values that cannot sustain normal 
cerebral metabolism and function or maintain tissue structure. The distinction 
between hypoxia and ischemia is not always that obvious, as they can both lead to 
cerebral oxygen deprivation and cell death. Ischemia differs from hypoxia in that it 
involves a reduction in blood supply as well as an interruption in the supply of 
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oxygen. There is therefore an accumulation of metabolic products in ischemia, which 
includes CO2, lactic acid and ammonia. 
The degree to which brain tissue is damaged depends on the duration and severity 
of ischemia. In the absence of an adequate oxygen supply, the tissue can obtain 
energy only by utilising energy-rich phosphate reserves, like those obtained from 
adenosine triphosphate (ATP) and adenosine diphosphate (ADP). When severe or 
prolonged, however, ischemia rapidly leads to cell death in the affected area of the 
brain. The severity of the injury depends on the extent of the ischemia and the 
location of the involved brain. These ischemic cerebral lesions in TBI ranging from 
small foci of neuronal necrosis to frank infarction, are relatively common in fatal 
blunt head injury (20, 22). Even brief periods of transient ischemia may result in 
selective neuronal necrosis that only manifests after hours, days, weeks or months 
(23-26). 
 When ischemia is incomplete, there is a reduction in CBF, but some residual ‗trickle‘ 
flow persists. To compensate, the brain increases the fraction of the oxygen content 
of arterial blood extracted, known as the oxygen extraction factor (OEF). However, 
this is a limited compensatory mechanism. Residual perfusion of the tissue may still 
permit an ongoing supply of glucose to the tissue, which ultimately leads to an 
increase in lactate production and cerebral acidosis. The degree of cerebral acidosis 
in incomplete ischemia, can therefore be more profound than in total ischemia.  
An analysis of the tissue metabolite levels, viz. ATP, ADP, lactate and pyruvate, 
provides an indication of the balance between mitochondrial energy production and 
usage. This may in turn provide an adequate method of evaluating the degree of 
circulatory restoration. Transient ischemia usually occurs in three phases : 1) the 
ischemic insult, 2) a period of complete or partial recovery of function and 
metabolism, and 3) a period in which secondary damage becomes manifest. The 
importance of identifying these phases is that the second phase may represent a 
window of opportunity to intervene (27). 
The thresholds for CBF in cerebral ischemia have been described by various authors 
over the years (28-34, 125). Reduction of cortical blood flow to levels of 
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approximately 20ml/100g/min often may be tolerated without any significant 
functional consequences, however, loss of consciousness and 
electroencephalographic slowing may occur. If CBF decreases below 
18ml/100g/min, ionic homeostasis becomes jeopardized and neurons convert to 
anaerobic metabolism (157, 158, 159). At a CBF of 10ml/100g/min, membrane 
integrity is lost and massive calcium influx ensues, leading to irreversible damage. 
Tissue infarction is also time-dependent, as discussed earlier, and will occur with a 
CBF of 5ml/100g/min lasting for more than approximately 30minutes, at a CBF of 
10ml/100g/min for more than 3 hours, 15ml/100g/min for more than 3.5 hours, or 
18ml/100g/min for more than 4 hours (160, 161).   These studies were done mostly 
on adult stroke models. The generalizability of these data to TBI, and children in 
particular, is limited by the complexity of TBI and the differences between adult and 
pediatric cerebral physiology.  
 
Classification of cerebral ischemia. 
Ischemia may be global or focal (35-38). Global ischemia may be brief, caused by 
global insults like cardiac arrest, which affect all brain areas similarly. Recovery from 
such insults have been reported only after ischemic periods of 15 minutes or less (at 
temperatures of 37-38 0C) (84). Focal ischemia is a different entity to global ischemia in 
many ways (35, 36, 39, 40). It may occur in cerebrovascular disease, subarachnoid 
hemorrhage (SAH) and TBI. The ischemia affects primarily the territory supplied by 
the affected vessel, while surrounding tissue is variably affected. Therefore the 
severity of the ischemia varies from dense ischemia in the area supplied by the 
occluded artery (the focus, or the core) and less dense ischemia in the surrounding 
areas that receive blood from collateral vessels (the penumbra) (46-50).  
Focal ischemia caused by MCA occlusion, differs from global ischemia because the 
reduction in CBF is less severe, but usually more sustained. And so there are 
significant differences in cerebral energy states during global ischemia and following 
MCA occlusion (42-45). Induced transient MCA occlusion for 15 to 18 minutes, in 
monkeys, showed no damage, with some tolerating occlusion for up to 60 minutes 
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(41). Focal tissue areas are usually irreversibly damaged, as their blood supply is 
usually too feeble to sustain the cells beyond the initial 15 to 30 minutes of ischemia. 
In contrast though, even when the perifocal areas are at risk, they remain viable for 
longer periods. With a good collateral supply, viability may be preserved for a few 
hours (46). The size of the infarcted tissue usually grows in size though, as the 
perifocal tissue is recruited in the infarction process. As this recruitment period takes 
some time, it may provide a ―window‖ of therapeutic opportunity during which 
perifocal tissue could be salvaged, by either pharmacological interventions or 
reperfusion. 
 
Mechanisms of ischemic brain damage: molecular changes and cellular death. 
Understanding of the complex mechanisms and interactions involved in the 
pathophysiology of ischemic brain damage, has in recent years increased 
considerably. Mitochondria within the brain are extremely sensitive to ischemic 
insults. The initial response to an ischemic insult is a substantial impairment in the 
electron transport chain, which may be followed at a later stage by reductions in the 
levels of ATP and phosphocreatine (PCr). The role of mitochondrial dysfunction in 
neural energy failure and cell death has been highlighted in both traumatic and 
ischemic brain injury (165, 166, 167). While cell death was traditionally thought to 
occur either by necrosis or apoptosis, recent arguments suggest that these are not 
separate and distinct events, but rather lie on a continuum (168, 169). Recent 
evidence suggests that these two systems are linked by the regulation of calcium 
(Ca2+) within the cell, and even more importantly, by the mitochondria (170). 
Decrements in the vasodilatory response to nitric oxide (NO), cyclic guanosine 
monophosphate, cyclic adenosine monophosphate, and prostanoids were all 
reported as possible mechanisms underlying posttraumatic hypoperfusion and 
subsequent ischemia (264-266).  In studies, done in pigs and rats, release of the 
vasoconstrictor, endothelin-1, post injury, and loss of endothelial NO production 
were postulated as possible mediators of the post-traumatic ischemia (267, 268). Loss 
of vasodilators and elaboration of vasoconstrictors may therefore have a significant 
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role in facilitating ischemic injury. It is, however, not clear whether the immature 
brain is more or less prone than the adult brain to develop hypoperfusion after TBI 
(272). 
The two major hypotheses to explain cell death, are the calcium hypotheses and the 
excitotoxic hypothesis. The calcium hypothesis proposes that massive influx of calcium 
into cells, due to disruption of the plasmalemmal Ca2+-ATPase (controlling efflux), 
leads to cell death by catalyzing the breakdown of structural components of the cell. 
These are mainly membrane lipids, cytoskeletal proteins and most importantly 
mitochondria (57, 58, 59). The excitotoxic hypothesis, suggests that excitatory amino 
acids (EAA) eg. glutamate, related toxicity leads to neuronal cell death in tissue (61, 
62, 64). Although glutamate is the most abundant neurotransmitter in the brain, 
exposure to toxic levels produces neuronal injury in two phases. Minutes after 
exposure, sodium-dependent neuronal swelling occurs, resulting in ―osmolytic 
damage‖. This is followed by delayed damage due to calcium influx (61-65). These 
processes initiate cell death by setting in motion various reactions viz. enhanced 
lipolysis, altered phosphorylation of proteins, enhanced production of reactive 
oxygen and nitrogen species, dissolution of the cytoskeleton and fragmentation of 
DNA. 
One of the major problems in understanding ischemic thresholds in TBI is that the 
quoted thresholds for CBF in cerebral ischemia, are based on studies done largely in 
adult stroke models. These thresholds may not be appropriate for ischemia in TBI as 
there are fundamental differences in the pathophysiology of the two conditions. The 
most important of these is the uncertainty regarding the metabolic activity of the 
brain and whether or not the altered CBF is coupled to an underlying metabolic 
depression. If there is uncoupling of metabolism, a normal CBF may actually be 
inadequate for areas of increased metabolism Increases in metabolic demands early 
after TBI related to uptake of glutamate, demonstrated by increased brain and CSF 
lactate levels, have been reported (269, 270) This difficulty in equating an absolute 
CBF value with ischemia in TBI, has led to the need for assessing other relevant 
parameters, which include OEF, CMRO2, SjvO2, CvO2, lacate /pyruvate ratio and 
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AVDO2. This need has stimulated numerous investigators to employ a variety of 
modalities in order to best demonstrate the burden of ischemia in TBI. These 

























CHAPTER 4:  Methods of monitoring for cerebral ischemia 
 
Detecting cerebral ischemia, or a surrogate marker of ischemia, can be attempted by 
using several different monitoring modalities. These may be either invasive or non-
invasive, allowing either a continuous or ‗snapshot‘ recording of local, regional or 
global brain functional parameters. They may directly measure tissue perfusion, 
oxygenation or metabolism or measure surrogate markers of the adequacy of 
oxygenation, like CBF, CBV, CPP and ICP. Invasive methods include, brain tissue 
oxygen tension monitoring (PbtO2), jugular venous saturation (SjvO2), cerebral 
microdialysis (MD) and CBF (thermal perfusion) monitoring, the key features of 
these monitoring techniques are summarized in table 1. Non invasive methods 
include imaging techniques like combined positron emission tomography (PET), 
xenon enhanced computed tomography (Xe-CT), perfusion computed tomography 
(perfusion CT), single photon emission computed tomography (SPECT), various 
MRI sequences and techniques, as well as other bedside or portable modalities, such 
as near infrared spectroscopy (NIRS), transcranial Doppler (TCD), 
electroencephalography (EEG) and somatosensory evoked potentials (SSEP), the key 




Brain tissue oxygen monitoring (PbtO2) 
Direct PbtO2 monitors are probably the most frequently used technique for 
measuring regional brain oxygenation, due to their relative ease of use (76). The 
most commonly used device is also the one about which there is the largest body of 
evidence in the literature, i.e Licox system (Integra Neurosciences, Plainsboro, NJ, 
USA). Other PbtO2 devices include the Neurotrend (Codman, no longer 
commercially available) and Neurovent-PTO (Raumedic, ICP and PbtO2). 
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PbtO2 is measured using a fine probe which is usually inserted into white matter 
parenchyma. The readings from the sampling area (about 14mm2) are determined by 
the amount of oxygen diffusing across a thin membrane, which covers the 2 
electrodes of a polargraphic cell (66). The cell used is a Clark-type electrode, which 
uses the electrochemical properties of noble metals to measure the oxygen content of 
tissue. Therefore the greater the oxygen partial pressure, the more oxygen diffuses 
through the membrane. PbtO2 readings are not a direct measurement of total oxygen 
delivery or cerebral oxygen metabolism. Rather, measurements of PbtO2  were 
shown to represent the product of CBF and arteriovenous oxygen tension difference, 
suggesting a strong association between PbtO2 and diffusion of dissolved plasma 
oxygen across the blood-brain barrier (158). 
The monitor provides a measure of PbtO2 in units of tension (mmHg). The readings 
obtained from these monitors are continuous, and have been shown to be reliable in 
vitro, with minimal drift over time (67-72). These readings are usually stable about 2 
hours after insertion, local tissue damage is minimal and complications are rare (68, 
69, 73, 74). The ease of use and potential benefit of continuous brain oxygenation 
monitoring, coupled with the ability to measure the response to interventions, 
render this method particularly appealing and increasingly popular in the 
neurointensive care unit (NICU) (75, 76, 77). PbtO2 guided management may also 
assist in deciding the optimal CPP for individual patients, so avoiding the 
potentially harmful effects of raising CPP in all TBI patients (207). However, the 
major limitations are the very focal measure of oxygen tension produced and the fact 
that several other factors influence PbtO2 readings, eg. inspired fraction of oxygen, 
hemoglobin level, arterial carbon dioxide level, cerebral oedema and anatomical 
location of the catheter tip. It is, therefore, not simply an ischemia monitor, although 
ischemia may be one of the important contributors to reduced PbtO2.    
 
Jugular venous saturation (SjvO2)  
SjvO2 was, for a long time, the most widely used method of monitoring cerebral 
oxygenation (78, 85, 86). SjvO2 measurements are obtained by placing a fiberoptic 
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oxygen-sensing catheter into the jugular bulb for continuous recording or 
intermittent sampling (78). The readings obtained are more indicative of global 
cerebral oxygenation or at least hemispheral oxygenation, which has been 
considered by some to be an advantage, when compared directly to PbtO2 (85). SjvO2 
monitoring offers continuous and real-time display, but is more susceptible to 
artifacts and reduced time monitoring (80). It is more prone to technical problems 
and vigilance is required to obtain reliable data. Frequent recalibration and special 
attention to matters such as poor light intensity, head movements, spontaneous 
waves, or sudden changes are required to obtain adequate ―time of good data 
quality‖ (81-83). The choice of which side to use has also been discussed, but most 
commonly the dominant hemisphere is chosen (84), although some may choose the 
more injured hemisphere or bilateral monitoring. Another potential shortcoming of 
SjvO2 monitoring, as demonstrated by Coles et al in 2004 (11), is the limited ability to 
provide reliable information about focal ischemia. This limitation of SjvO2, especially 
when compared to PbtO2 monitoring, has been a large factor in PbtO2 monitoring 
being used as the preferred method of monitoring cerebral oxygenation, especially in 
recent years (79,91). Various factors influence SjvO2, the two most important of 
which are CBF and cerebral metabolic rate of oxygen consumption (CMRO2).   
Therefore an increase in CBF or a decrease in CMRO2 may lead to an increase in 
SjvO2. Conversely, a decrease in CBF or increased CMRO2 leads to a decrease in 
SjvO2. The reference range for ‗normal‘ values for SjvO2 lies between 50% and 75% 
(86). A decrease in SjvO2 to below 50% for at least 10 minutes has been suggested as 
a critical threshold (87), however this is debated. Desaturation episodes correlate 
with a poorer outcome in patients who have sustained TBI, particularly when these 
episodes occur more than once during the patient‘s course of treatment (89, 94). The 
association of abnormal SjvO2 values with poor outcome has been demonstrated by 
numerous authors (87, 88, 89). However, it is not only low SjvO2 values which are 
negatively prognostic, as increased SjvO2 values have also been associated with 
poorer outcome (87). The association with low SjvO2, however, seems to be stronger 
(88). Ideally, other cerebral parameters should be monitored concurrently to assist in 
the interpretation of SjvO2 changes. An increase in ICP, decrease in CBF, or a 
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decrease in peripheral arterial blood saturation (SaO2), all improve the 
understanding of synchronous SjvO2 changes (95). In pediatric TBI, there is limited 
data correlating SjvO2 and outcome. The available data, however does suggest an 
association between more than one episode of SjvO2 readings below 50% and poorer 
outcome (92).  
 
Microdialysis (MD) 
Cerebral microdialysis (MD) was first introduced in the 1970‘s by Delgado and 
Ungerstadt (172, 173). The original idea was to implant an artificial capillary into 
brain tissue to facilitate sampling of interstitial fluid for analysis of neurochemical 
markers. However, it was only introduced as an intracerebral sampling method for 
clinical neurosurgery in 1990 (174) and has been embraced largely as a research tool 
to measure neurochemistry in TBI and other neurological conditions. The basic MD 
system consists of a catheter for tissue implantation and a perfusion pump. The 
diameter of the catheter is approximately 1mm. It consists of a double lumen and has 
a semi-permeable membrane attached at the tip. The dialysate used in MD, is a fluid 
that is isotonic to the interstitial fluid (ISF). This facilitates mass transport of 
molecules across the membrane which are driven by diffusion across a concentration 
gradient. Therefore, at a constant perfusion rate, the concentration of a certain 
molecule in the dialysate will be proportional to the concentration in the 
perfusate/ISF. This ratio is referred to as the relative recovery. The technique can 
therefore enable frequent sampling and monitoring of chemical changes in the ISF 
with a maximal time resolution of 1-20 minutes. Prior to the introduction of MD, 
neurochemistry of the brain was primarily evaluated indirectly via samples of 
cerebrospinal fluid (CSF). The greatest advantage offered by MD, was that it 
provided a semi-continuous method for analysis of the chemical constituents of the 
extracellular space, and thus also brought the hope for new insights into the 
neurochemistry of TBI and the possibility of neurochemical monitoring in 
neurointensive care management. The most notable neurochemical markers in TBI 
are aimed at markers of metabolism, including, glucose, lactate, pyruvate, 
32 
 
lactate/pyruvate ratio, lactate/glucose ratio and pH. While MD is one of very few 
methods for neurochemical measurements in the interstitial compartment of the 
human brain, it has several limitations restricting its use as a clinical monitoring tool 
in TBI patients. These include, concerns about the focality of monitoring, 
complicated issues related to quantification of data, implantation strategies, 
appropriate choice of markers, quality assurance, and the cost and infrastucture 
required. The role of MD, currently, remains as a research tool and its use has been 
restricted to a few institutions.  
 
Cerebral blood flow (CBF) via thermal perfusion monitoring 
Direct CBF/perfusion monitoring in TBI, has only been reported on by a few 
investigators (60,180,181,182). The technology originated from work done at the 
Massachusettes Institute of Technology (MIT), by Dr. H.F. Bowman. Perfusion 
monitoring aids in the assessment of tissue as well the reaction of tissue to induced 
physiological changes. It therefore, potentially facilitates rapid detection of change in 
perfusion level and allows recording of long-term perfusion levels to monitor 
changes over a course of treatment. The probe may be inserted via a cranial bolt, and 
is usually inserted to a depth of 2cm into the least injured hemisphere (158). The 
probe contains two thermistors embedded at the tip of a polyurethane catheter. The 
distal (heating) thermistor is heated to a small increment (approximately 2.5oC) 
above the tissue temperature baseline, while the proximal (sensing) thermistor tracks 
the tissue baseline temperature. The power dissipated by the heated thermistor 
provides a measure of the tissue‘s ability to carry heat by thermal conduction in the 
tissue and thermal convection in blood. The monitor measures tissue perfusion by 
determining the conductive properties of the tissue, and produces a real-time 
simultaneous measure of perfusion and temperature at the site. The accuracy of 
perfusion measurement is highly dependent on proper and stable probe placement, 
as the monitor is sensitive to motion artifact. The Bowman Perfusion Monitor 
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Non Invasive methods 
 
Positron emission tomography (PET) scan.   
The principle of PET imaging is based on the emission of a positron from the active 
isotope within the tissue. The emitted positron, a low energy particle, travels only a 
few millimetres before combining with an electron in the tissue. This collision results 
in annihilation of the two particles with the emission of two high energy gamma 
rays. These gamma rays are emitted in nearly exactly opposite directions, and are 
detected by a pair of external circumferential detectors, situated 180 degrees from 
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each other. The localizing capability and striking images provided by PET, rely on 
these detectors picking up simultaneous gamma ray signals. These images represent 
the quantitative distribution of a radiotracer of specific biologic importance. By 
comparing the clearance of the positron emitting isotope with the location of the 
annihilation event, this modality is able to provide critical physiological and 
biochemical measurements (282). Oxygen-15 positron emission tomography (O2 
PET) imaging has been used to determine cerebral blood flow (CBF), cerebral blood 
volume (CBV), cerebral metabolic rate of oxygen consumption (CMRO2) and oxygen 
extraction fraction (OEF). Some studies have suggested that this imaging modality 
may provide a robust and specific definition of true ischemia (12). PET scanning has 
also been used in conjunction with other monitoring tools and imaging modalities, 
as a ‗gold standard‘ to validate and refine bedside monitors of cerebrovascular 
physiology. It has also been used to study the impact and adequacy of therapeutic 
interventions aimed at treating and preventing cerebral ischemia. The relevance of 
using PET scanning to answer questions related to the pathophysiology of TBI, as 
well as assessments of the feasibility and safety of this modality have been validated 
by early seminal papers (109, 110). An acceptable definition of regional cerebral 
ischemia depends on the demonstration that CBF is inadequate for oxygen demands. 
This suggests that local OEF should be increased or CMRO2 decreased in these 
regions.  The triple oxygen study PET is the most commonly used protocol for PET 
scanning, providing information on CMRO2 and OEF. PET also has other capacities, 
beyond its application in demonstrating cerebral ischemia, including the additional 
information derived from fluorodeoxyglucose (FDG), fluoro-omisonidazole and 
PK1195, as markers of abnormal substrate handling in ischemia, tissue hypoxia and 
cerebral inflammation, respectively (112, 113). However, there are several distinct 
disadvantages of PET scanning. These include, most notably, the need to transfer 
patients out of a critical care environment (requiring stable patients), the need to 
administer radiation, relatively poor spatial resolution at 2-4 cm3 and the lack of 
‗within-modality correlations‘ (compared with magnetic resonance imaging). Most 
importantly, although PET allows detailed information to be derived, it is limited to 
a ‗snapshot‘ of the brain at one point in time, a significant limitation in practical 
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neurocritical care, given the temporal heterogeneity and dynamic nature of TBI. 
Finally, very few specialized centres have access to PET scanners due to the expense 
and infrastructure required.  
 
Xenon-enhanced CT scanning 
In this imaging modality, non-radioactive xenon gas is inhaled and the temporal 
changes in radiographic enhancement produced by the inhalation, are measured by 
sequential computed tomography. The importance of techniques designed for 
measuring CBF, both regional and global, have been well established by various 
studies demonstrating the importance of this relationship over the years (114, 115). 
The introduction of rapid, sequential transmission CT provides a method of 
monitoring changing tracer concentrations over time with a high degree of 
anatomical specificity (116, 117). The local CBF in extremely small tissue volumes is 
derived from measurements of time dependent concentrations of nonradioactive 
xenon gas. These methods employ sequential CT scanning of one or more brain 
slices during the inhalation of xenon/oxygen mixtures in order to detect the build-
up or wash out of xenon in tissue. Xenon is a freely diffusible tracer which readily 
crosses the blood brain barrier, its time dependent concentration in tissue can 
therefore serve as an indication of tissue perfusion. Xenon tends to yield measurable 
image enhancement even when it is inhaled in relatively low concentrations. This is 
largely due to the relatively high atomic number of xenon, i.e. 54. Local CBF is 
calculated using the Fick principle, which states that tissue uptake of an indicator is 
equal to the amount supplied by the arterial blood less the amount drained by the 
venous blood (118). Briefly, the actual procedure involves the acquisition of three or 
more images preceeding, during and/or after a period of four to six minutes of 
xenon/oxygen inhalation. During this period xenon concentrations in the inspired 
and expired gas are monitored continuously and end–tidal xenon levels are assumed 
to be proportional to time dependent xenon concentrations in arterial blood (119). 
The result is then used in conjunction with time dependent xenon concentrations in 
tissue to derive a partition coefficient and local CBF for each specific tissue of 
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interest. Most early studies reporting the results of Xe-CT were done on lightly 
anesthesized baboons, with normal and infarcted brains (119). Xenon concentration 
from 20-80% were used in these studies and the results indicate that while signal-to-
noise improves with increased concentration, time dependent patterns when xenon 
concentrations fall below 40 percent are similar to those observed with higher xenon 
concentrations. Using this methodology, flow can be consistently characterized in 
tissue with fast, slow and extremely slow flows (i.e. infarcted tissue).  
However, there are also significant shortcomings associated with Xe-CT, these 
include: the high dose of radiation due to repeated scans at the same level, patient 
motion during procedure, the side effects of xenon itself i.e. possible increase in ICP, 
EEG alterations and a slow decrease in local CBF and the fact that xenon is no longer 
FDA approved, restricting its use (in the USA). Like PET it has limited temporal 
resolution in that it provides a snapshot of the brain at one point in time. Unlike PET 
though, it does not allow the interpretation of CBF relative to the underlying 
metabolic activity of the brain. 
 
Single photon emission computed tomography (SPECT) 
SPECT is a functional neuroimaging technique which provides another non-invasive 
method for studying both physiological and pathophysiological changes in the 
human brain. SPECT is mostly used to demonstrate a patient‘s pathological status 
when neurological symptoms cannot be explained by structural neuroimaging 
findings alone. It is sensitive in detecting impairment in regional cerebral function 
when CT or MRI shows only non-specific findings e.g. cerebral atrophy. The defects 
noted on SPECT are also frequently larger than those noted on CT, largely because 
SPECT imaging represents a combination of a central zone of infarction, surrounded 
by a penumbra zone of ischemia, as ipsilateral cortical diaschisis may also contribute 
to the size of the defect (183). SPECT is also more sensitive than CT in the early 
(within 24 hours) detection of acute ischemia (183, 184). The high sensitivity in 
detecting functional impairment, however, is counterbalanced by poor specificity as 
the same SPECT pattern may be encountered in different pathologies. The 
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association between CBF, metabolism and neuronal activity is the basis for the use of 
brain perfusion SPECT. Interpretation of these images, therefore, requires a detailed 
knowledge of both the patient‘s symptoms and the functional areas of the brain 
likely to be involved. This can also be used to sequentially track changes in regional 
cerebral perfusion over time (185). The usage of brain perfusion SPECT as a clinical 
research tool has been favoured in the investigation of sensory, motor and cognitive 
studies (neuroactivation studies) as well as in the assessment of the effect of drugs 
on the central nervous system (pharmacologic challenge) (186). 
The appropriate selection of a radiopharmaceutical agent is important, as both the 
pharmacokinetics of the compound and physical characteristics of the isotopes 
influence the technical aspects of the investigation.  The common biological 
properties of these radiopharmaceuticals include: the ability to cross the blood-brain 
barrier, distribution in the brain proportional to blood flow and retention in the 
brain with a fixed regional distribution for a sufficient time to permit image 
acquisition (20-30 min). To quantify regional CBF (rCBF) by means of brain 
perfusion SPECT, the diffusible gas 133Xe, was previously considered the 
radiopharmaceutical of choice (187). Due to several limitations, including a rapid 
clearance time, a low gamma ray energy (causes poor quality images) and requiring 
active patient cooperation, however, it has fallen out of favour. Other brain SPECT 
tracers such as 123I-labeled amines {123I-isopropyliodoamphetamine (123I-IMP)} and 
technetium-labeled (99mTc) compounds {hexamethamethylpropylenaneamine oxime 
(99mTc-HMPAO) and ethylcysteinate dimer (99mTc-ECD)}, offer higher resolution 
SPECT images after intravenous administration. These tracers seem to have found 
more acceptance even though they allow only quantitative estimations through their 
tracer uptake ratios. Absolute rCBF measurement using SPECT has not been fully 
implemented and the region of interest (ROI) analysis of rCBF has become the 
preferred method of quantification (183). 
In the initial assessment of patients with mild and moderate TBI, SPECT was found 
to be more sensitive in detecting brain lesions than CT (187, 188). It is also 
particularly useful in patients with persistent neurobehavioural abnormalities after 
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mild degrees of trauma when the CT and MRI studies are normal. While SPECT 
imaging may demonstrate areas of hypoperfusion in TBI patients who have 
abnormal neuropsychological tests (188), the pathophysiology and prognostic 
significance of these findings remain unclear. 
 
Perfusion CT 
Perfusion CT is a technique that provides rapid qualitative and quantitative 
evaluation of cerebral perfusion. The main principle of perfusion imaging revolves 
around the analysis of plain and contrast-enhanced CT scans obtained at different 
times. The technique is based on the central volume principle, which relates CBF, 
CBV and mean transit time (MTT), using the equation: CBF = CBV/MTT. Perfusion 
studies therefore generate maps of CBF, CBV and MTT by monitoring the passage of 
an iodinated contrast agent through the cerebral vasculature. The linear relationship 
between concentration and attenuation, therefore leads to an increase in attenuation 
proportional to the amount of contrast in the region. Arterial and venous regions of 
interest (ROI) are generated, based on the time – concentration curves produced by 
these contrast agents. Complex mathematical calculations are then used for ‗ 
deconvolution ‗ of these enhancement curves, in order to generate a MTT. CBV is 
then calculated as the area under the curve, and using the central volume equation 
the CBF can then be calculated (189,190).  
The dose of radiation required for perfusion CT is 2.0-3.4 mSv, which is only slightly 
higher than that required for a routine CT head (1.5-2.5 mSv). This dose equivalent is 
less than the dose equivalent obtained with PET or SPECT and is comparable to that 
of a single level xenon CT examination (191,192).  The main clinical indications for 
the use of perfusion CT are: acute stroke, perfusion assessment in the acute phase of 
TBI, assessment of cerebrovascular reserve, temporary balloon occlusion tests, 
vasospasm in SAH and the measurement of microvascular permeability in tumours 
(193). 
In the acute phase of mild TBI, perfusion CT has detected abnormalities of CBF and 
CBV in cases where the admission non-contrast CT scan was normal (194). The 
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applicability and prognostic significance of this investigation in acute TBI lies in its 
ability to better delineate the ambiguous nature of hypodense areas on non-contrast 
CT that may represent either necrotic or viable tissue (195). The depiction of brain 
perfusion abnormalities and their regional heterogeneity early on in pediatric and 
adult TBI, could significantly impact the diagnosis, aggressiveness of treatment and 
may also offer valuable prognostic information (196,197). 
 
MRI sequences 
Magnetic resonance imaging (MRI) has an important role to play in assessing brain 
injury in children. Unfortunately, most MR sequences are designed for imaging the 
adult brain and need to be adapted to obtain high quality images of the immature 
brain with its high water content. Conventional MRI sequences provide excellent 
and detailed information about the pattern of lesions following pediatric and 
perinatal brain injury. Specific advanced MRI techniques may provide additional 
relevant and prognostic information, when evaluating ischemic brain injury. These 
techniques include diffusion-weighted imaging (DWI), diffusion tensor imaging 
(DTI), perfusion–weighted imaging (PWI) and magnetic resonance angiography 
(MRA). 
Diffusion-weighted imaging (DWI) is a measure of the random motion of water 
within tissue. The apparent diffusion coefficient (ADC) provides a means of 
quantifying this random motion or diffusivity. In children, DWI has been used 
mostly to assess tissue injury in neonates with perinatal stroke (230). The evolution 
of the diffusion abnormality in perinatal ischemic brain injury appears to be similar 
that seen in adults (231). In order to improve the sensitivity of detecting abnormal 
tissue, a fluid-attenuated DWI technique is often used, particularly where the partial 
volume effect of CSF may make ADC values inaccurate (232). Reduced ADC values 
within the brainstem of neonates with perinatal brain injury have been reported, but 
it is still unclear whether ADC values provide a more sensitive measure of later 
outcome following perinatal stroke (233,234). To maximise the predictive abilities of 
the diffusion techniques to correctly identify ischemic tissue, it is essential to 
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consider the timing of the injury, the age of the patient and the conventional imaging 
appearances, together with the DWI characteristics and ADC measurement. 
Diffusion tensor imaging (DTI) is a diffusion-weighted technique which allows the 
measurement of the directional diffusivity of water or anisotropy as either regional 
(RA) or fractional anisotropy (FA). Anisotropy has been shown to be useful for the 
timing of an injury in adults, demonstrating no hyperacute changes within 6 hours 
of symptoms (235). Anisotropy increases with age because myelination results in 
decreased radial diffusivity perpendicular to white-matter tracts, and is variably 
deranged following acute focal infarction (236). A combination of ADC and FA 
values derived from DTI combined with visual analysis of conventional imaging 
currently offers the best approach for identifying abnormal tissue and estimating the 
timing of the insult (237). 
Perfusion-weighted imaging (PWI) most often is used to assess tissue viability in 
adult stroke, usually in conjunction with DWI. Contrast enhanced PWI techniques 
are generally preferred to non-contrast techniques like arterial spin labelling, due to 
the poor signal to noise ratios (SNR) of the latter. PWI may have many applications 
in studies of the neonatal brain but there are few studies published (238). The main 
difficulties with PWI studies in the immature brain are motion artifact, difficulties in 
obtaining data of the normal brain, and problems with quantification. Perfusion of 
the neonatal brain shows regional heterogeneity. Neonates with extensive white 
matter infarction may show both relative under and over-perfusion of this tissue. 
Although PWI has already allowed insights into the response of the immature brain 
to hypoxic-ischemic injury (237), it remains a challenging technique in the very 
young because the pathologies and reponses of the brain are different. 
Magnetic resonance angiography (MRA) is a well established non-invasive 
technique for imaging the intracranial vasculature at 1.5 Tesla and lower magnetic 
field strengths, mostly in adults. Neonatal imaging, using the same technique to 
study vessel anatomy and blood flow, has been relatively underutilized (237). 
Angiography of the circle of Willis and carotid arteries and venograms of the dural 
sinuses are useful for describing anatomic variations and determining whether these 
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predispose to brain inury in a given clinical situation. Compared to adult vessels, 
neonatal vessels are smaller, with lower blood flow velocities, making MRA of the 
immature brain a technically challenging technique, not only for visualizing the 
vasculature, but also for performing quantitative diameter and flow measurements. 
Therefore, MRA protocols need to be adapted for neonates, by shortening scan times 
to prevent motion artefact, use of low flip angles and out-of-phase imaging in order 
to better saturate the subcutaneous fat and implementation of ramped radio 
frequency pulses and multiple thin volume strategies to maintain intravascular 
signal at the distal cortical branches. Time-of-flight and phase-contrast angiography 
are the two MRA imaging techniques regularly used to visualize neonatal brain 
vessels (237, 238). 
 
Electroencephalography (EEG) 
The close correlation between cerebral electrical activity and the level of CBF 
required to maintain neuronal metabolic function, makes monitoring of EEG activity 
during periods of potentially compromised perfusion to the brain an appealing 
modality. Analog EEG classically becomes abnormal (suppressed EEG) when CBF 
falls below 20-25ml/100g/min (239), these EEG abnormalities include: 1) loss of fast 
beta frequencies (12-30 Hz), 2) slowing of background into 5-7 hertz theta frequencies, 3) 
slowing into delta range (1-4-Hz), and 4) flattening of the EEG with burst-suppression. One 
study showed improvement in the EEG as patients were given hypervolemic 
therapy, and ischemic conditions improved (240). Although these EEG abnormalities 
may be present during cerebral ischemia, they are not very specific to cerebral 
ischemia. 
The mean dominant EEG frequency of 6.5Hz was found to correlate with CBF levels 
of 33-39 ml/100g/min, and when the mean dominant EEG frequency increased to 
7.8Hz, CBF improved to 47 ml/100g/min. These results suggest that EEG may serve 
as a continuous qualitative measure of CBF, assuming that EEG activity is coupled 
with CBF (241).  
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Quantitative EEG (QEEG) measures such as compressed spectral array (CSA) and 
frequency analysis trending have proven more useful in acute ischemic disease, and 
in particular for critical care physicians not accustomed to interpreting EEGs. 
Changes in EEG can be quickly identified by changes seen in the QEEG, which 
allows one to view a smaller portion of EEG for clinical correlation (242). The acute 
EEG and QEEG, therefore, may provide useful information that can be integrated 
with other parameters to ascertain changes in CBF in the acutely ill patient. 
 
Somatosensory evoked potentials (SSEP) 
The detection of brain ischemia by monitoring SSEPs is an appealing technique, as 
the somatosensory cortical projections are situated on the hemispheric convexity and 
are, therefore readily accessible to scalp electrodes. The choice of lower limb 
(posterior tibial nerve) or upper limb (median nerve) SSEP monitoring may to some 
extent be guided by the tissue most at risk. At the functional CBF threshold, a further 
decrease in CBF leads to desynchronisation of cortical neurons, which leads to a 
decrease in the amplitude, or even disappearance of some peaks on the monitor 
(243). It should also be noted that SSEP monitoring has a low specificity for cerebral 
ischemia. SSEP latencies are also less sensitive than amplitudes to a decrease in CBF, 
because the metabolic needs of axons located in white matter are lower than the 
neuronal bodies found in grey matter. Hence subcortical structures are more 
resistant to brain ischemia, owing to lower metabolic needs (244, 245). Quantitative 
criteria for decreased CBF include: 1) more than 50% decrease in N20 amplitude and 2) 
an increase in central conduction time (CCT) of more than 1ms or more than 20 from 
baseline (246, 247, 248). Qualitative criteria for SSEP alterations have been  classified 







Near infra-red Spectroscopy (NIRS) 
The use of NIRS for the detection of decreases in oxygenated Hb, and subsequently 
as a measure of cerebral oxygenation was first reported by Jobsis (93).  This 
technology has shown its usefulness in a variety of clinical applications, including 
the detection of cerebral ischemia during carotid endarterectomy (96, 97), regional 
perfusion abnormalities in neonatal cardiopulmonary bypass (98), endoscopic 
thoracic sympathectomy (99) and cardiopulmonary bypass (100, 101). With regard to 
its application to cerebral ischemia detection in TBI, it is an appealing method for 
bedside monitoring of cerebral oxygenation that is both non-invasive and 
continuous. The infrared beam is generated from a light source and passes through 
the tissues and is detected by one or more optodes placed a short distance away 
from the source. NIRS monitoring is based on the fundamental principle that light in 
the near infrared spectrum (700-1000 nm) will penetrate tissue and that the 
attenuation of this light is determined by various factors, including the oxidation 
status of hemoglobin and enzymes in the mitochondrial respiration chain. These 
characteristics facilitate the ability to measure the concentration of substances within 
the brain due to the difference in oxygen dependent absorption of near-infrared light 
passing through (102). The calculation of brain oxygen saturation is determined by 
comparing the relative concentrations of both types of hemoglobin viz. 
oxyhemoglobin and deoxyhemoglobin, as derived by their differing infrared 
absorption capacities.  
NIRS is a particularly suitable application for neonates and young children, as their 
skulls and soft tissue are thinner, compared to adults. NIRS monitoring has 
progressed quite significantly since earlier days when only simple wave analysis 
was available. Modern machines are able to provide more data relating to ‗spatially 
resolved‘ spectroscopy as an absolute measure of cerebral tissue oxygen saturation. 
However, interpretation of NIRS is subject to much baseline variation, due mostly to 
individual as well as disease related thresholds. Normal values however, are 
thought to lie between 60% and 75% (103), but much debate still persists regarding 
the level and length of time beyond which the damage incurred is irreversible. 
Therefore NIRS is more helpful when readings are compared to a stable baseline, for 
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example in cardiac anesthesia and surgery, than in the neurocritical care, where a 
normal patient baseline may difficult to obtain (250). In TBI, NIRS recording may be 
adversely affected by subgaleal hematomas, subarachnoid and subdural collections 
and cerebral oedema (104-106). There are also concerns that NIRS may not be able to 
detect areas of ischemia (107) and that normal readings have been registered in areas 
where SPECT scans have demonstrated no CBF and also in dead subjects (106, 108).  
 
Transcranial Doppler sonography (TCD) 
The use of TCD in neurosurgery was introduced by Aaslid (161). This device enables 
non-invasive transcranial measurement of the blood flow velocity in large basal 
intracranial arteries. Measurements of middle cerebral artery blood flow velocity 
often are used in the care of TBI patients, and are particularly accurate in the 
detection of episodes of hypoperfusion induced by low CPP (256). However, it is 
important to note that TCD provides a measure of CBF velocity and not CBF 
directly.  
TCD is a portable technique that uses a low frequency (2-Mhz), pulsed Doppler 
transducer to measure the velocity and pulsatility of blood flow within the circle of 
Willis and vertebrobasilar system (175). Doppler measurement of intracranial blood 
flow velocity is based on the detection of frequency shifts from insonated red blood 
cells (RBC) moving through a small, preselected arterial spatial region, ‗the sample 
volume‘. This sample volume is determined by the lateral focusing of the transducer 
and the duration of the transmitted sound burst at a specific pulse repetition rate. 
The diagnostic accuracy, however, is subject to the knowledge, skill and experience 
of the user. TCD can be performed on any patient, ambulatory or comatose, so long 
as they are able to remain stationary in the supine position. The examinations can be 
performed through four naturally occurring windows i.e transtemporal, transorbital, 
transforaminal (foramen magnum) and submandibular. Depending on the clinical 
situation, a complete examination through all available windows may be used, but 
this is rarely necessary in the context of TBI. The spectrum of intracranial vascular 
abnormalities in which TCD is useful, includes SAH, vascular malformations, TBI, 
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brain death confirmation and arterial stenosis. In TBI, vasospasm may occur with 
traumatic perivascular hemorrhage and may lead to focal or generalized increases in 
flow velocity, which are detectable with TCD. In absence of vasospasm, high flow 
velocities may imply hyperemia. Also, disturbances of autoregulation can be 
examined with TCD by tracking the flow velocity response to changes in blood 
pressure, as can be the response to CO2 changes (85, 141).  
Insonation of the MCA is usually performed through the temporal window. The 
depth of insonation giving the highest mean velocity (Vm) is usually chosen. Indices 
which can be measured are, peak systolic velocity (Vs), end-diastolic velocity (Vd) 
and time-averaged mean velocity (Vm). These can be used to calculate the pulsatility 
index (PI), as follows: PI = (Vs – Vd) / Vm (255). The PI is considered normal if it is 
between 0.8 and 1.2 (258). Increased PI [>1.2] usually occurs because of increased 
cerebral peripheral resistance eg. raised ICP or hypocapnia (258, 259).  The absolute 
value of the PI, however, was found to be a poor indicator of raised ICP in children 
with severe TBI, a high PI in this study seemed to have a stronger association with 
low CPP (283).  A decreased PI [<0.8], may be caused by decreased peripheral 
resistance or downstream to high grade stenoses eg. arteriovenous malformations 
(258, 259). The Lindegaard ratio is used to distinguish vasospam from normal blood 
flow. It relates the MCA blood flow velocity (VMCA) to the blood flow velocity in the 
ipsilateral extracranial  internal carotid artery (VICA), using the formula : VMCA / VICA. 
A threshold value of 3.0 for the VMCA / VICA index was proposed to differentiate 
vasospasm from hyperemia (260). A minimal yet significant increase in this ratio, 
with age, was noted by Krejza et al (261). Using transcranial colour Doppler 
sonography, they also noticed substantial fluctuations of the VMCA / VICA index in 
age-matched male and female groups, suggesting gender related variability in 
cerebral blood flow velocities. In pediatric patients, poor cerebral hemodynamic 
status, as evaluated using TCD on admission to the emergency room, correlated with 
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It is clear that there are many ways to diagnose and monitor aspects of CBF patterns 
and oxygenation in the injured brain. The various modalities discussed above, each 
have distinct advantages, which encourage their continued use in the setting of TBI, 
however each of these have significant limitations, so there is no ideal monitor for 
brain perfusion and oxygenation in TBI.  
Recent literature still favours the use of PET scanning as a comparative standard. In 
some centres this is combined with MD recordings, as the current ‗gold standard‘ for 
measuring CBF and detecting global cerebral ischemia (11, 109, 110, 111). There is 
however a growing body of evidence in favour of PbtO2 monitoring (71, 73, 74, 75, 
76, 77, 176, 178, 179) as a useful tool, particularly when used in conjunction with ICP 
monitoring, for continuously assessing the adequacy of brain tissue oxygenation. 
Although it is not an ischemia monitor, it may play a useful role in the detection of 
ischemia because ischemia is an important cause for low PbtO2. The specific 
diagnosis of ischemia, however, will depend on the use of ancillary investigations. 
 The context of monitors such as PbtO2 is fundamentally different to that of the 
various imaging modalities. PbtO2 is used as a monitor in the neurocritical care unit, 
while PET and other imaging modalities are used primarily as a research tools or for 
more information at a single point in time. The bedside continuous monitors may be 
limited in the information they can provide and their spatial resolution is poor. On 
the other hand, imaging modalities have better spatial resolution, and may provide 
very detailed information, but have little temporal resolution in a condition that is 
highly dynamic. Arguably, a better understanding of the pathophysiological 
52 
 
changes in TBI, for example brain ischemia, may be achieved by combining the 
information that one gets from these different modalities, rather than relying on a 
single modality, or group of modalities, for precise answers. 
The ideal monitoring modality would be non-invasive, provides continuous real-
time recordings, good temporal and spatial resolution, is inexpensive, easy to use 
and interpret and does not require transfer of the critically ill patient out of the ICU. 
While such a monitoring modality remains elusive and probably unlikely, in reality, 
the best way to monitor the management of TBI patients probably lies in employing 
a multimodality approach, aiming to combine information regarding regional and 
global CBF patterns, ICP and oxygenation. While the combination of these various 
modalities continue to provide information about the state of CBF, the parameters 
they measure differ, and the values suggested by some of the more important 
studies on the subject differ as well. The relevant studies examining the occurrence 















CHAPTER 5: Literature review of clinical studies assessing 
cerebral ischemia in traumatic brain injury. 
 
Early reports describing ischemia as an important secondary insult in severe TBI 
were based on the histopathological findings in postmortem studies of TBI. The 
antemortem diagnosis of secondary ischemia however, has proved more elusive and 
controversial. Recent studies addressing the issue have variably used PET scanning 
or Xe-enhanced scanning techniques, microdialysis and PbtO2, but there are 
substantial differences between imaging and ICU monitoring techniques, as 
discussed previously. 
There is variability in the risk of ischemia reported in these studies in part due to 
differences in the methodologies used, timepoints evaluated, and definitions of 
ischemia. This section reviews some of the important studies on secondary injury, 
including ischemia, in adult and pediatric TBI to highlight the major issues. It is 
divided into five parts, viz. studies based on histopathological findings, studies 
based on PET and MD findings, studies based on Xe-CT findings, studies assessing 
both SjvO2 and PbtO2 in TBI, and finally studies that were specifically pediatric in 
nature. The key findings of these studies provided in Table 3. 
 
i) Studies based on histopathological findings  
Early reports on the post-mortem appearances of ischemia in fatal head injuries 
emanated from the seminal work done by Graham and Adams (13). In this study, 
published in 1978, the authors set out to determine the incidence and distribution of 
ischemia related brain damage in patients who died as a result of non-missile head 
injury. They performed both neuropathological and neurohistological examinations 
on 151 consecutive post-mortem specimens from patients who died due to severe 
head injury. The authors documented ischemic damage in 91% of cases, after 
excluding cases where necrosis and infarction were related to contusions or fat 
embolism and cases where infarction of the brainstem was thought to be typically 
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due to raised intracranial pressure. In 27% of these cases, the ischemic damage was 
found to be severe, in 43% it was found to be moderately severe and in 30% was 
found to be mild. The anatomical regions in which these areas of infarction were 
concentrated were, the hippocampus, basal ganglia and cerebellum. The authors 
also demonstrated a statistically significant correlation between demonstrated 
ischemic brain damage and, either an episode of hypoxia or raised ICP. The findings 
in this seminal paper demonstrated that ischemic brain damage is common after 
head injury, and is at least in part, potentially avoidable. It was also one of the 
earliest studies to highlight ischemic brain injury as an important cause of morbidity 
and mortality after head injury, as well as to attempt to demonstrate the frequency 
of ischemia in head injury (22). However, because these were postmortem data, the 
results of the study did not provide an understanding of the incidence of secondary 
ischemia in survivors of TBI or quantify the risk in patients being actively managed 
in the neurocritical care unit. So the question remained: was secondary ischemia a 
major finding only in patients who died because of severe TBI, or was it a common 
and potentially preventable secondary injury in all patients with severe TBI? 
 
ii) Studies using Xe-CT scans 
A study by Bouma et al (15), suggested that while the role of ischemia in TBI was 
important in fatal head injury (13,14), CBF studies done subsequently, had failed to 
demonstrate this as a common occurrence. Therefore they postulated that the 
measurement of CBF in these studies had not been performed early enough to detect 
cerebral ischemia, i.e. during the period of highest risk for posttraumatic ischemia. In 
their study, they used Xe-CT scans and AVDO2 measurements, aiming to evaluate 
the occurrence of ischemia early in head injury by performing the initial 
measurements within the first 6 hours post injury. Their results suggested global 
ischemia (CBF<18ml/100g/min) in 12.9% of patients, at some point after injury. 
They also demonstrated, however, that in the first 4-6 hours post injury, the mean 
CBF was lower than at any point thereafter and that critically low CBF 
(<18ml/100g/min) was found in 33% of these cases.  They also found that early 
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cerebral circulation and metabolism disturbances i.e. within the first few hours post 
injury, were the most important factors correlating with both clinical status (motor 
score in the GCS) and outcome. The limitations to this study were that the decrease 
in CBF demonstrated, may not actually reflect an inability to meet the metabolic 
demands of the tissue, but may reflect decreased CMRO2 coupled with CBF found 
after head injury. The fact that all patients who had intracranial mass lesions were 
not evaluated, due to the obvious need for urgent surgical evacuation also excluded 
a significant segment of patients. The Xe methodology used in this study also has a 
relatively poor spatial resolution and may therefore miss significant areas of regional 
or focal ischemia. These shortcomings need to be borne in mind when interpreting 
these results. 
Another important study by the same group in 1992 (159), aimed to perform ‗ultra 
early‘ CBF measurements. The method of measuring CBF in this study, differed from 
that of the previous study, in that the stable Xe-CT method used in their later study 
is considered to have a higher spatial resolution and therefore allows for a more 
precise correlation between flow and anatomy. The time after injury at which the 
studies were performed, ranged from 50 minutes to 8.5 hours (mean of 3.1 hours). 
The overall incidence of cerebral ischemia, both regional and global, in this series 
was 31.4%. This figure is slightly lower than the 33% shown in the previous study 
and contradicts the speculation made in that study, that ―with earlier measurements 
(<4 hours post injury) an even higher incidence of ischemia would be found‖. The 
possible reasons suggested by the authors for this discordance was that a relatively 
large number of patients with normal CT scans, who followed commands within 48 
hours, in this group, would probably have been excluded from the previous group 
and that this group did not include some of the most seriously injured patients with 







iii) Studies done using PET scans and MD. 
A study by Vespa et al in 2005 (142) examined the subject of metabolic dysfunction 
in relation to ischemia in 19 adult TBI patients using PET and microdialysis (MD) at 
a mean time of 36 hours post injury. The latency from injury to PET was 60 ± 30 
hours after injury. Using PET, they were able to examine regional CBF, OEF, CMRO2 
and cerebral metabolic rate of glucose (CMRglu). The parameters used to define 
cerebral ischemia in this study, were an OEF > 0.75, coupled with a cerebral venous 
oxygen content (CvO2) <3.5ml/100ml. Microdialysis parameters included the 
lactate/pyruvate ratio (LPR) and cerebral glucose levels. These were also used in the 
definition of ischemia or mitochondrial dysfunction viz. glucose < 2mmol/L and 
LPR > 40, as initially proposed by Landolt in 1994 (90). The results of this study 
suggested a prevalence of post-traumatic ischemia of 1% of total brain volume 
(TBV). However, the frequency of metabolic dysfunction was higher, which the 
authors termed ‗metabolic crisis without ischemia‘, implying mitochondrial 
dysfunction without necessarily a substrate delivery problem. These findings were 
similar to those from a study by Diringer et al (141), which examined the regional 
cerebrovascular and metabolic effects of hyperventilation after TBI. The OEF, CBF 
and CMRO2 values at a baseline arterial carbon dioxide (PaCO2) concentration of 
40mmHg were similar in both studies.   The findings of the Vespa et al (142) study 
showed a lower mean ischemic brain volume (IBV) of 1.5cm3, which translates into 
1.5% of total brain volume. Limitations of this study, however, include the following: 
the PET scans were performed at later time points after injury when compared to 
other studies, with imaging performed at a mean time after injury of 36 hours. This 
limitation means that earlier episodes of ischemia during a higher risk period may 
have been missed. Importantly, these results also reflect a single point in time, 
whereas acute TBI is a dynamic condition. Finally, PET scans require patients to be 
stable before transport to the imaging facility, which may select patients at times that 
are relatively lower risk for ischemia. 
Another important PET study was reported by the Cambridge group (11) in 2004. 
The results from this study were based on PET imaging data used in combination 
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with arterial tracer activity measurements and jugular bulb specimens. These 
findings were used to assess CBF, CBV, CMRO2 and OEF. PET studies were 
undertaken in both normal volunteers and head injury patients, within 24 hours of 
injury. The burden of ischemia was ultimately assessed using the OEF. The benefit of 
using OEF is that the confounding effects of drug and injury induced metabolic 
suppression on CBF and CMRO2 are avoided. The OEF values used to define critical 
ischemia in this study, were based on a formula using CaO2 values from arterial 
samples, then subtracting CvO2 from these values. CvO2 was identified as a critical 
predictor of infarction in experimental ischemia values below 2.9ml/100ml (143).  
These OEF thresholds were then used in applications to facilitate the calculation of 
the volume of voxels with a CvO2 value below this threshold and hence allowed 
estimation of the ischemic brain volume (IBV). The IBV data was then compared to 
data derived from SjVO2 samples using traditional threshold values for SjvO2 and 
AVDO2 (50% and 9ml/100ml, respectively) (144-148).  The results showed a 
significantly lower CBF and CMRO2 and a higher CBV and OEF value in the head 
injury patients, when compared with the control group. The estimated IBV was also 
higher in the head injury group, with ischemic values of between 1 – 16% of total 
brain volume (TBV). These ‗ischemic voxels‘ seen on the PET images, were found 
mostly adjacent to contusions or intracranial hematomas (ICH) in the frontal, 
temporal and parietal regions. Of note the SjvO2 threshold in the presence of 
ischemia was higher than that described in previous studies (144, 147). SjvO2 values 
of 50 % were only found when a substantial proportion of the brain was potentially 
ischemic, approximately 170 ml, which equates to about 13% of the TBV. The 
investigators also emphasized the fact that PET imaging represented a snapshot of 
the brain metabolic state and while it does provide an indication of the burden of 
ischemia at the time of imaging, it does not take into account of the duration of such 
ischemia. This means that transient ischemic events eg. focal seizures, may 
temporarily increase oxygen demand during the scan and subsequently cause an 
increase in OEF resulting in the IBV overestimating the burden of ischemia. 
Conversely, ischemia may develop at other times during the patient‘s illness and 
adversely affect outcome, but would remain undetected during a single scan. The 
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‘snapshot‘ IBV figure would therefore underestimate the overall burden of ischemia 
over the course of the patient‘s illness. The data in this study does suggest that while 
high OEF values may represent ischemia, the pathophysiology may be more 
involved than that seen in ischemic stroke. The coexistence of relative ischemia and 
hyperemia in some patients may represent a more fundamental problem with 
matching of perfusion to oxygen use after head injury. A recommendation made by 
these authors is that other imaging modalities such as proton magnetic resonance 
spectroscopy (1H MRS) be used at follow up to validate the thresholds used to define 
critical ischemia. The authors suggested that OEF provides the only valid indicator 
of the adequacy of CBF and oxygen delivery and is independent of CMRO2. A high 
OEF was found to denote an imbalance of flow–metabolism coupling, which is 
characteristic of tissue at high risk of ischemic injury.  
A later PET study by the same group, also in 2004 (111), demonstrated that hypoxic 
regions in the injured brain may be less able to increase OEF than previously 
assumed, due to ‗diffusion barriers‘ which limit oxygen diffusion in the injured 
brain. They used PbtO2 values of less than 10 mmHg to define the ischemic 
threshold for tissue. SjvO2 values were used to calculate the AVDO2. Controlled 
hyperventilation was used to decrease the CBF, and the PbtO2, AVDO2 and OEF 
calculated for the hypoxic regions of the brain, demonstrated an attenuated ability to 
increase OEF. They concluded that global or regional OEF, as a marker of 
hypoperfusion, underestimates the burden of ischemia in TBI.   
 
iv) PbtO2 and SjvO2 studies 
PbtO2 and SjvO2 studies are worthwhile examining, because even though they are 
not necessarily ischemia monitors, they are both continuous monitors that may 
detect ischemia in the ICU. A study by Rosenthal et al (158), using PbtO2 and CBF 
monitoring modalities, evaluated whether PbtO2 more closely reflected cerebral 
oxygen diffusion or cerebral oxygen delivery and consumption. They investigated 14 
TBI patients, using a combination of an oxygen challenge, MAP challenge and 
hyperventilation challenge, to assess tissue oxygen reactivity, autoregulation and 
59 
 
cerebral vasoreactivity, respectively. The findings from this study suggest that PbtO2 
is most closely related to CBF and AVDO2, and this implies a relationship between 
the amount of dissolved plasma oxygen and the oxygen concentration in brain 
tissue. The authors found this to be consistent with their hypothesis that it is the 
diffusion of dissolved plasma oxygen, rather than total oxygen delivery, that is 
related to PbtO2. This suggests that PbtO2 is not an ischemia monitor per se, but 
rather that low PbtO2 values are more complex, and in particular may be affected by 
low CBF, low PaO2, and oxygen diffusion through the tissue.  
Hlatky and colleagues (149) evaluated the monitoring and treatment of intracranial 
hypertension and cerebral ischemia as secondary injury processes in the injured 
brain.  Several factors were highlighted as contributing to PTCI. These included 
systemic arterial hypotension, increased ICP, cerebral oedema, focal tissue 
compression from hematomas and microvascular diseases. The authors therefore 
suggest that the ideal monitoring technique for cerebral ischemia would give 
regional information about CBF as well as providing continuous information about 
the evolution of CBF over time after injury. They divide the available techniques into 
two categories, viz. techniques based on perfusion and techniques based on 
adequacy of flow. The most widely used of the latter group are the SjvO2 and PbtO2. 
Both of these techniques are indicative of the adequacy of flow relative to the 
cerebral metabolic requirements in the involved region of the brain. While raised 
ICP is quoted as the most common cause of SjvO2 desaturation in this study, a major 
limitation of SjvO2 monitoring is its limited ability to identify regional ischemia. In 
conditions like TBI where there is considerable regional heterogeneity of CBF 
pattern, monitoring of PbtO2 is suggested as more advantageous, in this study. The 
normal values for PbtO2 listed in this study are approximately 20 to 40 mmHg, with 
a critical threshold of 8 to 10 mmHg. 
 A study by Kiening et al (67), correlated an SjvO2 of 50% with a PbtO2 of 8.5 mmHg. 
The authors suggested this value as a critical threshold. They conclude by suggesting 
that stable Xe-CT be used to obtain intermittent measurements of regional CBF, if no 
hypoperfused regions are detected via this modality, then a global monitor such as 
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SjvO2 was suggested. If significant heterogeneity of flow was demonstrated, 
however, PbtO2 monitoring was recommended as the preferred monitoring 
modality. Whichever of these modalities were ultimately chosen, using the 
abovementioned recommendations, would then to be used in conjunction with ICP 
monitoring. 
 
v) Pediatric specific studies 
Clinical studies aimed at demonstrating the pathophysiological changes occurring 
after severe TBI, have involved mainly adults, with pediatric TBI representing only a 
small proportion of the population. An understanding of the dynamic nature of the 
pathophysiology of TBI (both in children and in adults) is fundamental to a rational 
management protocol, particularly aimed at the prevention or amelioration of 
secondary injury. 
Early studies suggested that increased CBF (cerebral hyperemia) was a common 
occurrence in pediatric TBI (284, 290, 291). In a study investigating the relationship 
between CBF, AVDO2 and CMRO2 in pediatric TBI, Sharples et al (285) found 
increased CBF after severe TBI in children to be an uncommon finding. They also 
demonstrated an inverse relationship between raised ICP and CBF, as well as a fall in 
CMRO2 with time, suggesting that CMRO2 may be at its highest early after TBI. 
These findings, taken in context of the study by Bouma et al (15), as discussed earlier, 
suggest that the risk of ischemic brain injury may be highest in the first few hours 
after TBI.   
In another paper by the same group (286), the role of cerebrovascular resistance 
(CVR) in pediatric severe TBI was explored. They found a significant correlation 
between cerebrovascular resistance and CPP, concluding that pressure 
autoregulation in this group of patients was often intact. They also found CMRO2 to 
be a strong determinant of CVR, which was interpreted as reflecting appropriate 
metabolic coupling in this group of patients. This finding was in contrast to data 
published by Muizelaar et al (287), who suggested that metabolic uncoupling after 
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TBI was a significant occurrence. The main reason postulated by the authors (286) for 
this disparity, was that Muizelaar et al had compared their AVDO2 results with 
normal values in adults, as opposed to normal AVDO2 values in children. In both the 
studies published by Sharples et al (285, 286), they suggest that ―the pathophysiology 
of TBI in children is essentially not different from that in adults‖. 
The results of the study by Muizelaar et al (287) demonstrated hyperemia in a 
significant number of the CBF measurements they conducted (88%). CBF and 
metabolism were found to be completely uncoupled 24 hours post-TBI, as 
demonstrated by a high CBF and low AVDO2. The lack of a clear relationship 
between CBF and CBV, led to the conclusion that increased CBV may play an 
important role in pediatric TBI, even though it may not always be accompanied by a 
high CBF. The authors also did not support the contention that vascular factors play 
a stronger role than CSF factors in determining ICP after TBI, as suggested in an 
earlier study (291). 
A recent study (76) using PbtO2 monitoring in children with severe TBI (GCS ≤8) 
examined the association between various patient factors, including PbtO2, with 
outcome. The main findings of this study were that episodes of low PbtO2 (in 
particular, PbtO2<10 mmHg) were found to have an independent association with 
mortality and poor outcome (measured by the Glasgow Outcome Score and the 
Pediatric Cerebral Performance Category Scale), PbtO2 was reduced to lower values 
and for longer periods of time in patients who had a poor outcome. PbtO2 also 
appeared to have a stronger association with outcome than ICP and CPP in 
multivariate analysis. Thus PbtO2 tends to have a similar association with outcome in 
children as in adults. The above study was not able to determine a difference in 
PbtO2 thresholds across age ranges, however, it is possible that the sample size was 
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The disparity between the findings in the studies using different methodologies to 
examine the problem of secondary cerebral ischemia after TBI is quite apparent. The 
earlier histopathological studies suggest that the occurrence of PTCI is very high, at 
least in fatal cases, with ischemic damage documented in 91% of cases. Studies using 
Xe-CT suggest a frequency of between 12.9% and 33%. Data from PET and MD, 
suggest a much lower frequency of PTCI than others, they however define their 
results in terms of IBV, with figures of between 1% and 6% of TBV. 
The findings in these studies are affected by numerous factors, which revolve mostly 
around what is being monitored and the temporal and spatial resolution of the 
monitoring modality. The timing of the investigation is an important feature, as the 
risk of ischemia seems to be higher in the early post injury phase (15).  The 
heterogeneity of CBF patterns in the post injury phase, increases the difficulty, as 
global methods may miss regional ischemia and the reliability of focal methods, 
depend on appropriate selection of the site for monitoring. The paucity of literature 
specifically relating to pediatric TBI, its pathophysiology and age-related changes, 
make this area of study particularly challenging. 
Despite the limitations of point-in-time imaging modalities, PET scans remain the 
‗gold standard‘ modality in the detection of cerebral ischemia, and have provided 
some of the most reliable data to date. The results yielded by the most recent studies 
using this modality, have suggested a relatively low prevalence of ischemia, but this 
may be limited by the aforementioned factors peculiar to PET scanning.  
This leads to the central aim of the present work: to examine how single datapoints 
of PbtO2 measurements (a widely used modality) in patients with TBI, taken at 
discreet timepoints post-TBI, compare with each other and with the overall 
frequency of ‗adverse‘ PbtO2 events over the full duration of monitoring. In essence 
this would use a single technology and compare a snapshot technique with data 
available from continuous monitoring. The hypothesis of the study is that events 
that may be detected at a single point in time after TBI depend on the timing of the 
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study, and may not reflect the overall risks of these events occurring over the full 




























It is generally believed that cerebral ischemia, or brain hypoxia is an important 
contributing factor to secondary injury and poor outcome in TBI. Point-in-time 
imaging techniques may have good spatial resolution and can examine more aspects 
of brain perfusion and metabolism than continuous monitors but cannot quantify the 
overall burden of the problem over the full time period during which the brain is 
vulnerable to these insults because TBI is a highly dynamic condition. Often these 
studies can only be performed in patients who are stable enough, both for transport 
and for prolonged imaging, whereas unstable patients, who are more likely to be at 
risk of adverse secondary events, are usually not imaged. Therefore these 
investigations may not give the treating physician a sense of how common these 
potentially injurious events may be. This is important because some studies suggest 
a relatively low prevalence of ischemia after TBI (11, 15, 142, 159). Other modalities 
used in the ICU may give less information than imaging techniques and may be 
more spatially limited, but have the advantage of being able to monitor the patient 
continuously. These appear to suggest a higher burden of events that may be 
ischemic in nature in TBI patients (13, 14, 75, 76). The discrepancy may lie not only 
with the methodology used, but also the fact that one is comparing frequencies 
reported at a single point in time with frequencies determined from monitoring 
continuously over the full duration of the acute period after TBI. 
The purpose of this study is to examine the relationship between the frequency of 
adverse events occurring at 2 selected time points post-severe TBI in comparison 
with the overall frequency of these events occurring over the full duration of 
monitoring. To do this, a retrospective study was undertaken of a large cohort of 
children with severe TBI. PbtO2 monitoring was selected as a single monitor to 
examine these data. Although a PbtO2 monitor is not an ischemia monitor per se, 
evidence is accumulating that episodes of low PbtO2   are associated with poor 
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outcome and so it appears to represent a means of detecting adverse secondary 
events after TBI, of which cerebral ischemia is one. As such it would be useful as a 
continuous monitor for the assessment of the burden of these events over a 
prolonged period of monitoring. Although the data cannot be compared directly 
with the data from imaging studies, one would expect that it should reveal some of 
the dynamic nature of changes in TBI, the principles of which should apply to data 
derived from studies performed at a single point in time.  
 
Study design 
This study was a retrospective review of prospectively collected data of children 
with severe TBI who received a PbtO2 monitor. All data were obtained from the 
neurotrauma database at the Red Cross War Memorial Children‘s Hospital. 
Informed consent was taken for monitoring of each patient from the parent or 
guardian of the child. Approval for the work was obtained from the Human Ethics 
Board of the University of Cape Town. 
  
Methods and materials 
All children who sustained a severe head injury (post resuscitation GCS ≤8), or who 
deteriorated to this level after admission were admitted to the ICU and considered 
for invasive monitoring, including a PbtO2 monitor, unless the patient was 
improving and it was anticipated that early extubation could be achieved. These 
patients were then managed in the ICU using an institutional protocol aimed at 
preventing secondary injury, based on the current Guidelines for the Management of 
Severe TBI in Children and Adolescents (288, 289).   
Significant mass lesions were removed surgically as soon as possible. ICP and PbtO2 
monitors were inserted in the operating room or by the bedside in the ICU. General 
therapy was aimed at controlling ICP and optimizing CPP. ICP was measured using 
a parenchymal monitor [Codman ICP Express (Codman, Raynham, MA, USA) or 
Camino (Integra Neurosciences, Plainsboro, NJ, USA)]. ICP was treated when it was 
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increased to > 20mmHg for more than 5 minutes. Treatment was instituted in a 
stepwise manner, first using basic measures such as sedation +/- paralysis, 
hyperosmolar therapy (hypertonic saline or mannitol), and ventricular drainage 
(where possible), and then proceeding to second-tier therapy if the increased ICP 
was resistant to these measures. These second tier therapies included barbiturate 
coma and decompressive craniectomy. In general, CPP was maintained greater than 
50mmHg in older children, or greater than 45mmHg in children less than 2 years 
old. The approach to maintenance of CPP was influenced by the status of 
autoregulation, the PbtO2 recording, and whether there was underlying respiratory 
injury. 
 
PbtO2 monitoring and treatment: The PbtO2 monitor was usually placed in right 
frontal white matter that appeared relatively uninjured on the head CT scan, or on 
the side of greater injury. Occasionally, in patients with focal injury, a PbtO2 monitor 
was placed in a peri-contusional location, this was the case in a very small number of 
patients and did not warrant a subgroup analysis. All patients underwent head CT 
scanning after monitor insertion to confirm location of the probe. The treatment 
target for PbtO2 was 20mmHg. In general, more aggressive measures to increase 
PbtO2 were used when PbtO2 decreased to below 10-15mmHg. The approach to 
treating reduced PbtO2 began with a search for possible causes, including increased 
ICP or reduced CPP, systemic hypoxia or hypercarbia, anemia, subclinical seizures, 
or vasospasm. Measures used to increase PbtO2 depended on the patient‘s condition 
and were individualized. In general, these included more aggressive treating of ICP, 
when ICP was borderline, increasing CPP when safe, blood transfusion, increasing 
PaCO2 when ICP was not significantly increased, and increasing the inspired 
fraction of oxygen. 
All data from the intracranial monitors were monitored continuously and recorded 
hourly. More recently, data were also recorded continuously at a sampling 
frequency of 50 Hz using a dedicated data collection system (ICMPlus®, Cambridge 
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University). Patients were monitored until their ICP and PbtO2 readings remained 
stable for 24-48 hours and extubation was planned. 
Data analysis 
PbtO2 data were analysed at two specific time-points after the time of injury, i.e. 
early and late. The 24 hour time-point after injury (early) was selected to represent a 
relatively early post-injury time that still took advantage of the fact that monitoring 
in many patients started after 12 hours post-injury. The 72 hours after injury (late) 
time-point was selected to represent a time-point midway through the post-injury 
course. In addition, the first 24 hours of PbtO2 monitoring was examined, as well as a 
24-hour period around the 72 hour mark, i.e. from 12 hours before to 12 hours after 
the 72 hour mark. All data were analysed only after a 2 hour run-in period for the 
monitor had elapsed, to avoid any artefactual data from a PbtO2 monitor that was 
still stabilizing. Although our treatment threshold for PbtO2 treatment is 20mmHg, 
PbtO2 < 10mmHg was selected for analysis as a measure of low PbtO2 because of the 
stronger association with outcome in adult and pediatric studies, including data 
from our own institution, and because of laboratory data showing a strong 
association with CBF decreased below critical thresholds (67, 76, 148, 150,). 
Additional data recorded included clinical data (neurological examination and 
systemic injuries), arterial blood gas results, the inspired fraction of oxygen on the 
ventilator, serum sodium, MAP and ICP. 
 
Patients were excluded from analysis if 1) the patient had not been monitored at the 
24-hour or 72-hour mark (monitoring started too late or was terminated before the 
time-point), 2) data were missing, 3) the patient died before the selected time-point, 
4) the PbtO2 catheter had been misplaced, i.e. not in white matter (as viewed on head 







Means and standard deviations or medians and interquartile ranges (IQR) are 
reported based on normality of data distribution. Significance was set at p=0.05. 
PbtO2 at 24 hours post-injury was compared with PbtO2 at 72 hours hours post-
injury. In addition, the full first 24 hours of monitoring were compared with the 24 
hours of monitoring surrounding the 72-hour mark. The PbtO2 / FiO2 ratio was 
similarly compared. Finally a generalized estimating equation was used to compare 
these values while accounting for inter-individual differences between patients. 
 
Results 
A total of 100 children less than 14 years old with severe TBI, were admitted to the 
pediatric ICU and underwent PbtO2 monitoring between June 2006 and January 
2010. Overall, PbtO2 was monitored for 11,700 hours in 100 patients. Thirteen 
patients were completely excluded for the following reasons: 1) Unknown time of 
injury (4), 2) Misplaced catheter (2), 3) Neither 24/ nor 72 hour data (1), 4) Died 
before 24 hours (4), 5) Catheter dislodged/malfunction (2). This left 87 patients for 
analysis (Figure 1). 
Of these, 7 patients were excluded from the 24 hour time-point for the following 
reasons: 1) Monitoring started after 24 hours (6), 2) Patient in the operating room at 
the 24 hour mark (1). Therefore, 80 patients were left for examination at the 24 hour 
time-point. 
For the 72 hour time-point, 10 patients were excluded from analysis for the following 
reasons: 1) Missing data (1), 2) Monitoring ended before 72 hours (7), 3) Died before 












The age distribution of patients in this study was: < 2years (n=15, 15%), 2-6 years 
(n=41, 41%), 7-10 years (n=28, 28%), and 11-15 years (n=16, 16%). There were 67 
males and 33 females. Road traffic incidents were the most common cause of injury 
(79%) and 61% sustained polytrauma. Median GCS before monitoring was 6 (range 
3-8), median motor response was 4 (range 1-5). General demographic data are shown 







Table 1. General demographic data. 
Age  Number 
 <2 years 15 
 2-6 years 41 
 7-10 years 28 
 11-15 years 16 
   
Gender   
 Male 67 
 Female 33 
   
Mechanism of injury  
 Blunt assault 2 
 Crush injury 4 










   
 
 
The average duration of monitoring was 5.8 ± 3.2 days (range 1-15 days), and on 
average patients stayed in the ICU for 8 ± 4.2 days (range 1-21 days). Apart from 
poor placement of PbtO2 probes there were no complications associated with any of 
the PbtO2 monitors. 
 
Summary of general physiological data   
Mean PbtO2 for pooled data for the duration of monitoring was 32.8 ± 12.9 mmHg 
(range 0-98.9). The day of lowest mean PbtO2 (for pooled data) was day 1 (mean 
PbtO2 24.6 mmHg) and the day of highest PbtO2 was day 6 (mean PbtO2 34.8 
mmHg). Mean ICP and CPP were 14±6.7 mmHg and 67±14mmHg respectively. 
Respiratory indices were as follows: mean ventilator FiO2 49±17, mean arterial 
partial pressure of oxygen 19.5±10kPa, and mean arterial partial pressure of carbon 
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dioxide 4.7±1.1kPa. Hemoglobin was 10.8±1.7g/dl and mean serum sodium was 
143±5.8mmol/L (Table 2). 
 
Table 2. General physiological data over full duration of monitoring. 
Physiological  
parameter 
Range Q1 Mean Median Q3 Standard 
deviation 
PbtO2 0-98.9 23.8 32.77 31.2 39.9 12.87 
MAP 30-125 73 81.6 81 90 13.10 
ICP 0-76 10 14.52 14 18 6.7 
CPP 2-124 58 67.12 67 76 14.44 
FiO2 10-100 40 48.95 45 60 17.16 
PaO2(ABG) 
(kPa) 
4.28-78.1 12.2 19.58 17.5 24.7 10.03 
 pCO2 (kPa) 1.8-13.5 3.91 4.66 4.6 5.24 1.12 
Hemoglobin 5.6-17 9.6 10.77 10.6 11.9 1.72 
Q1= first quartile, Q3=third quartile, PbtO2=brain oxygen tension, MAP=mean arterial pressure, ICP=intracranial 
pressure, CPP=cerebral perfusion pressure, FiO2=inspired fraction of oxygen, PaO2=partial pressure of oxygen, 
pCO2=partial pressure of carbon dioxide 
 
Analysis of selected time-points 
Summary values: Mean PbtO2 was 25.8±13.3 mmHg at the 24-hour post-injury mark 
(early), and 33.9±12.7 mmHg at 72 hours post-injury (late). For the whole first 24 
hours of monitoring and the 24-hour period around the 72-hour mark, mean PbtO2 
was 27.4±11.7 mmHg and 33.0±12.0 mmHg respectively. The ratio of PbtO2 / FiO2 
for the first 24 hours was 0.60±0.33, and for the later period was 0.79±0.41. When we 
compared the results of the early and late periods for patients who had data at both 
time points, PbtO2 at 24 hours was significantly less than PbtO2 at 72 hours (p<0.001). 
The mean difference was 7.98 mmHg (95% confidence interval 4.32 to 11.65), or 31% 
higher at the later time-point compared to baseline. Using a generalized estimating 
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equation to account for inter-individual differences, the results at the earlier period 
were also significantly less than the later period for all parameters examined, i.e. 
PbtO2 during the first 24 hours versus at the 72-hour mark (p<0.001, mean difference 
6.42mmHg), and the PbtO2 / FiO2 ratio in the first 24 hours versus the 24 hours 
around the 72 hour mark (p<0.001, 34% higher at the later time-point) (Table 3). 
  
Table 3. Physiological data at 24 hour time point. 
Physiological 
parameter 
Range Q1 Mean Median Q3 Standard 
deviation 
PbtO2 1.3-91.6 16.9 25.77  25.1 33.7 13.3 
MAP 47-110 71 78.09 75 86 12.31 
ICP 1-66 10 15.86 15 19 9.09 
CPP 27-95 53 62.10 61 68 13.50 
FiO2 21-93 40 51.53 50 60 16.23 
PaO2 (ABG) 
(kPa) 
10-37.9 23 25.44 25.8 28.95 7.39 
pCO2 (kPa) 2.6-6.19 3.41 4.12 4.1 4.78 0.92 
Hemoglobin 9.4-11.6 9.4 10 9.5 10.1 1.07 
Temperature 35.4-39.3 36.72 37.21 37.2 37.6 0.81 
Sodium 131-155 139.5 142.91 142.5 145.75 6.18 
Q1= first quartile, Q3=third quartile, PbtO2=brain oxygen tension, MAP=mean arterial pressure, ICP=intracranial 
pressure, CPP=cerebral perfusion pressure, FiO2=inspired fraction of oxygen, PaO2=partial pressure of oxygen, 








Table 4. Physiological data at 72 hour time point. 
Physiological 
parameter 
Range Q1 Mean Median Q3 Standard 
deviation 
PbtO2 15.9-68.6 24.37 33.95 32.1  42.92 12.71 
MAP 55-109 72 80.88 80.5 89 11.92 
ICP 1-44 10 14.3 13 18 7.09 
CPP 41-100 56 66.68 67 74.5 13.47 
FiO2 21-50 40 46.72 40 50 16.15 
PaO2 (ABG) 
(kPa) 
8.8-34 10.7 16.88 12.1 24.4 7.92 
pCO2 (kPa) 3.63-7.07 4.12 4.85 4.93 5.35 0.97 
Hemoglobin 8.4-13.3 9.7 10.92 10.4 12.25 1.62 
Temperature 34.6-39.5 36.5 36.87 37 37.35 0.88 
Sodium 141-149 143 144.7 144 146.5 2.75 
Q1= first quartile, Q3=third quartile, PbtO2=brain oxygen tension, MAP=mean arterial pressure, ICP=intracranial 
pressure, CPP=cerebral perfusion pressure, FiO2=inspired fraction of oxygen, PaO2=partial pressure of oxygen, 
pCO2=partial pressure of carbon dioxide 
 
 
Frequency of low PbtO2: At the 24 hour mark, PbtO2 was <10mmHg in 8 patients 
(10% of the patients examined at the 24 hour mark) and <5mmHg in 3 (3.8%). Two of 
these patients were hemodynamically unstable at the time. At the 72 hour mark, 
none of the patients had a PbtO2 <10mmHg, and only 7 patients had PbtO2 

















Figure 3. Initial 24 hour period compared to 24 hour period around 72 hour mark. 
 
    
 
Q1=first quartile, min=minimum, Q3=third quartile, max=maximum 
Q1=first quartile, min=minimum, Q3=third quartile, max=maximum 
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Figure 4. Comparison of FiO2 / PbtO2 ratio – initial 24 hour period vs. 24 hour 





Table 5. Episodes of low PbtO2 at 24-hour time point. 
At 24 
hours 
PbtO2 <20 PbtO2 <15 PbtO2<10 PbtO2 <5 
N=80 25 12 8 3 
Percentage
(%) 
31.25 15 10 3.75 
 
 
Table 6. Episodes of low PbtO2 at 72-hour time point. 
At 72 
hours 
PbtO2 <20 PbtO2 <15 PbtO2 <10 PbtO2 <5 
N=77 7 0 0 0 
Percentage
(%) 
9.09 0 0 0 
Q1=first quartile, min=minimum, Q3=third quartile, max=maximum 
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When examined over the full course of monitoring, episodes of PbtO2 <20mmHg 
occurred in 77 of 87 patients (88%), <10mmHg in 47 patients (54%) and <5mmHg in 
18 (21%). 
 




PbtO2<20 PbtO2<15 PbtO2<10 PbtO2<5 
N=87 77 63 47 18 
Percentage
(%) 
88.50 72.41 54.02 20.68 
 
Discussion 
The occurrence of cerebral ischemia in the pathophysiology following severe TBI is 
well established (121, 22, 124), but the frequency is often debated. As discussed 
earlier, postmortem studies suggest a high incidence of PTCI (13, 14, 22), but 
antemortem detection of early ischemia has remained difficult to demonstrate, 
despite numerous attempts using various modalities (11, 12, 15, 142, 149, 159). The 
difficulty in conclusively demonstrating this elusive entity lies largely in the 
discordance regarding the definition of ischemia and the limited spatial and 
temporal resolution of the various modalities employed. Therefore, comparison 
between studies is difficult and the treating clinician is left wondering about the true 
risk of ischemia in patients with acute severe TBI.  
The difficulty in reaching a widely accepted definition of ischemia arises because of 
several reasons. Earlier studies examining CBF in experimental and clinical 
environments described ischemia in terms of CBF thresholds i.e. less than 
18ml/100g/min (157, 158, 159). However, this does not take into account the issue of 
coupling between metabolism and CBF. In some patients, low CBF may be 
appropriately coupled with reduced metabolism. On the other hand, relatively 
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‗normal‘ CBF may be inappropriately low in the presence of increased metabolic 
demand. More recently, studies in TBI have evaluated not only CBF, but also OEF, 
AVDO2, PbtO2, CvO2, SjvO2 and lactate/pyruvate ratio (81, 129, 11, 78, 67, 17, 27). 
The various modalities employed, and their benefits and limitations in the 
management of TBI patients, have been discussed in chapter 3. None of these 
modalities provides a complete picture of the problem of ischemia in TBI. Imaging 
modalities such as PET have increased specificity for diagnosing ischemia, but it 
may not be possible to extrapolate these results to the full period during which 
patients are potentially at risk of ischemia, and in particular unstable patients, 
because of its limited temporal resolution and dependence on relatively stable 
patients that can be moved out of the ICU. Methods employed in the neurocritical 
care unit as monitors of brain oxygenation or metabolism have increased sensitivity 
for detecting adverse events, including ischemia, over the full duration of 
monitoring, but lack specificity for the diagnosis of ischemia because several factors 
influence their readings. 
PbtO2 as a monitor for ischemia and tissue hypoxia has specific limitations. First it is 
a focal monitor, therefore it reflects accurately only tissue that is being monitored. 
However, it appears that monitoring in ‗uninjured white matter‘ in a diffusely 
injured brain may reflect global changes in the rest of the brain (74). Second, several 
factors influence PbtO2, therefore it is not an ischemia monitor per se. However, 
experimental and clinical data demonstrate a consistent decrease in PbtO2 when CBF 
is reduced (67, 141, 148, 150, 156), therefore it is likely that when ischemia occurs 
(and affects the area being monitored, as in a global insult), PbtO2 is likely to be 
reduced. However, it must be remembered that several other factors may also lead to 
a decrease in PbtO2.  
The identification of cerebral ischemia remains an appealing quest, as there may well 
be an element of reversibility to the compromised tissue if it is detected early. The 
window of opportunity to intervene, however, is short before the damage incurred 
becomes permanent. This justifies the resources expended by numerous 
investigators aiming to quantify the burden of ischemia. 
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Comparison of results  
The results from this study show a relatively low prevalence of low brain tissue 
oxygen at the selected timepoints, as defined by PbtO2 <10mmHg, which may be 
due to ischemia or other causes of tissue hypoxia. As expected, PbtO2 early after 
injury is lower than at a later time point. Mean values on day 2 were 31-36% higher 
than the corresponding values in the first 24 hours. This is consistent with other 
publications reporting lower values for PbtO2 and CBF early in the post-injury phase 
and a higher frequency of cerebral ischemia or hypoxia. The differences are slightly 
less when one examines a longer period of time, rather than a single 24 or 72 hour 
time-point, as was done here with the first 24 hours compared with the 24 hour 
period surrounding the 72-hour mark, likely because a longer period dilutes some of 
the differences that occur over time. Arguably, if an earlier time point was selected, 
say 6-12 hours after injury, the frequency of low PbtO2  may have been higher. At 
hour 24 after injury, PbtO2 was <10mmHg in 10% of patients, while at the 72 hour 
mark, no patient had PbtO2 <10mmHg. On the other hand, when the full duration of 
monitoring was examined, as many as 88% of patients had episodes of PbtO2 
<20mmHg, 54% had episodes <10mmHg, and 21% had episodes <5mmHg. These 
results are consistent with the known dynamic nature of TBI. Each of these episodes 
is potentially clinically significant, even though they may be temporary. However, 
they may occur at unpredictable times after TBI is sustained. These results support 
the concept that the timing of the study after TBI substantially affects the findings, 
i.e. studies early after TBI are likely to detect more adverse events, but also that 
regardless of the timing of the study, caution must be exercised when interpreting 
the findings of a study that is limited to a single point in time in a head-injured 
patient. Given that there is no perfect monitor that has both good spatial and 
temporal resolution, this would suggest that the burden of cerebral ischemia, or 
other adverse events post-TBI, should be best interpreted using data from both static 
imaging technologies and dynamic, continuous monitors in the ICU.  





There are several potential limitations to this study. First, as discussed above, a 
PbtO2 monitor is not an ischemia monitor per se. Several factors influence PbtO2, in 
particular arterial partial pressure of oxygen. However, reduced PbtO2 is likely to be 
clinically significant, regardless of the cause. Reduced CBF is one of the important 
causes for low PbtO2, and PbtO2 consistently decreases when CBF is reduced 
experimentally. Reduced PbtO2 is associated with poor outcome in adults and 
children and so likely represents a clinically important adverse event. It is possible 
that the combination of PbtO2 with a complimentary modality, such as micodialysis 
(MD) or CBF may yield a more specific estimate of ischemia. Second, PbtO2 is a focal 
measure of tissue oxygenation and may miss ischemic/hypoxic events occurring 
elsewhere in the brain.    Therefore, current data may underestimate the true 
frequency of reduced tissue oxygenation. Third, the patient sample is a pediatric 
cohort of patients whereas the data from most of the studies discussed in this work 
involve adult patients and these may not be completely comparable. Therefore, the 
results of this study require validation in an adult cohort. However, the frequency of 
reduced PbtO2 between adults and children appears to be similar, and low PbtO2 is 
independently associated with poor outcome in both. Moreover, this study 
emphasizes the principles of comparing frequencies at single time points and over 
the full duration of monitoring, rather than specific values, so it is not unreasonable 
to generalize these results. Fourth, the PbtO2 threshold of 10 mmHg may not be the 
most appropriate threshold for detecting ischemia or critical tissue hypoxia. Some 
authors suggest a lower threshold of 6-8 mmHg. On the other hand, most centres 
treat PbtO2 when it is reduced below 20mmHg. Much work still needs to be done to 
better understand the association between PbtO2 thresholds and ischemia/critical 
tissue metabolic events. Still, regardless of the threshold chosen, the principle of 
comparing one threshold at different time-points, should be similar at different 
PbtO2 thresholds. PbtO2 less than 10mmHg has a strong association with outcome in 
pediatric and adult TBI (17, 67, 74, 75, 76, 263) and experimentally, PbtO2 less than 10 
mmHg also corresponds with classic measures of tissue ischemia (41, 129, 148, 150, 
154, 171, 215, 263 ).  Fifth, the study employs a single modality of monitoring, the 
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results of which cannot necessarily be generalized. However, the principle of the 
differences inherent in comparing single point-in-time data with data collected 
continuously over a long period should apply to all modalities used to measure 
adverse events occurring after TBI. 
It is clear that much work still needs to be done to assess the true risk of cerebral 
ischemia in patients with TBI, and more importantly whether this ischemia can be 
effectively reversed to improve outcome. At present, the frequency is debated. This 
is an important issue, because if cerebral ischemia is a relatively common event 
causing secondary injury, then this should direct treatment protocols. Improved 
outcomes seen in both adult and pediatric TBI patients, using treatment strategies 
aimed at the maintenance of adequate oxygenation and perfusion are well 
documented (77, 176, 178, 179), however, it is difficult to demonstrate conclusively 
that secondary ischemic events are being effectively detected and treated, and that 
this leads to better outcome. More specific data on which elements of these strategies 
are effective, especially with respect to the prevention of brain ischemia, would 
better inform global strategies to improve outcome after TBI. Without these data, 
clinical care is likely to continue with some uncertainty as all therapies to reduce the 
risk of brain ischemia or tissue hypoxia, such as increased CPP and normobaric 
hyperoxia, have potential risks when applied uniformly to all patients. Selecting 
which patients are at particular risk of developing ischemia or tissue hypoxic events, 
may allow aggressive targeted therapy to patients who stand to gain the most from   
this approach. 
 
Conclusion    
Although cerebral ischemia is thought to be an important factor causing secondary 
injury in TBI, current evidence does not clarify what the burden of ischemia in TBI 
truly is because of the complexity of its diagnosis. Although imaging techniques 
such as PET are superior in terms of spatial resolution and the indices of metabolism 
that can be measured, the results of this study suggest that selection of individual 
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time-points for examination, especially for stable patients, may significantly 
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